Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.7	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.4	0.0	0.1	7.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	11.4	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.7	0.0	0.0	0.0	0.2	0.5	0.2	33.8	2.9	0.0	0.0	2.2
AC138696.1		ENSG00000264668			8	143247110-143276403	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.8"									"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	3.6	4.8	6.2	2.5	4.4	1.5	2.5	5.8	7.3	3.3	3.8	4.7	2.5	2.6	5.7	2.7	2.8	7.8	2.0	2.7	6.2	4.8	2.6	1.9	2.7	2.5	4.8	3.0	5.8	6.8	4.6	4.5	2.2	4.2	3.0	2.2	3.8	3.6	3.9	4.7	1.8	3.1	3.2	3.7	2.7	2.7	3.5	3.6	1.5	2.7	1.5	2.6	3.6	4.4	0.6	0.6	0.0	0.2	0.9	2.1	0.1	1.4	0.0	0.0	0.8	4.8	0.3	0.5	1.4	3.0	1.6	0.6	0.0	1.9	0.2	0.8	0.3	0.3	0.7	0.0	0.6	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.3	0.7	2.8	1.3	0.0	1.0	0.5	0.9	1.1	0.0	0.1	0.0	0.0	3.3	0.0	3.0	0.4	0.9	1.6	2.8	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	1.0	0.9	0.0	0.0	0.7	3.0	0.1	2.3	0.8	1.6	1.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.9	0.2	0.6	0.3	0.1	6.2	4.4	5.8	7.3	6.2	4.8	4.8	3.0	4.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell type enriched"	"Detected in many"	21	"Hepatocytes: 4646.2"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 52.5;OE19: 40.2"					"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	230000000	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.3	3.4	0.8	0.0	8.6	10.3	0.1	1.4	3.0	0.4	1.4	2.0	1.8	0.1	0.4	4.2	2.9	1.3	0.9	1.0	0.4	5.8	1.3	0.3	1.9	52.5	1.8	1.3	0.1	8.3	0.8	0.5	1.8	4.3	2.0	1.5	0.0	9.6	1.2	0.2	0.2	0.4	0.2	40.2	3.8	0.2	1.3	3.9	0.8	1.0	0.0	0.1	1.5	0.6	2.3	1.9	1.4	0.2	1.7	0.5	1.0	0.5	0.2	2.0	1.6	0.2	1.1	0.6	1.6	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4	26.8	12.4	18.0	36.0	24.2	0.0	0.6	219.1	60.2	18.2	10.4	0.0	1.5	10.0	27.6	0.7	12.2	37.1	23.3	27.7	3.3	31.0	52.1	0.0	4646.2	15.9	0.0	68.2	70.0	110.5	1.1	65.9	16.0	21.9	1.0	138.3	9.1	26.8	17.3	22.6	45.5	0.6	12.9	18.6	0.7	1.0	45.8	7.8	12.1	44.2	29.8
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014113-65022184	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 847.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	39.6	32.0	37.3	17.7	78.7	19.8	26.8	16.1	46.5	21.2	23.5	34.7	13.4	23.9	26.8	20.2	23.7	35.2	22.4	52.6	34.8	32.7	33.8	6.6	23.1	14.8	36.1	38.2	27.2	29.9	22.5	15.4	25.5	32.7	25.3	15.5	30.3	26.9	33.1	78.3	19.6	23.4	28.2	44.9	16.7	18.9	31.4	28.7	7.9	26.3	23.6	12.9	24.7	22.8	43.7	37.8	18.7	21.8	21.0	40.7	34.7	36.1	57.7	17.9	26.4	48.6	36.9	16.3	17.8	41.3	25.6	25.3	16.3	25.0	14.0	34.1	25.1	39.0	23.3	18.8	31.4	12.2	14.6	29.5	14.1	26.0	24.6	37.2	17.1	12.8	29.0	26.3	21.3	47.8	37.4	34.0	16.9	33.2	26.1	17.2	42.8	14.1	38.5	28.0	17.2	47.1	7.5	19.6	33.6	27.5	15.8	33.3	18.8	15.3	15.9	50.2	17.6	16.6	21.0	25.6	48.3	16.3	38.3	18.4	9.0	12.6	8.6	22.8	24.7	39.2	10.2	21.8	18.7	34.8	21.2	37.6	43.7	32.2	33.6	27.6	37.3	36.8	40.7	2.8	21.0	12.4	37.8	20.6	34.7	37.3	78.7	16.1	46.5	34.8	32.7	36.1	38.2	32.7	28.7	20.8	35.8	37.0	78.1	72.4	72.3	89.8	50.9	32.1	52.4	78.5	27.5	165.9	227.1	118.2	362.1	147.4	126.8	46.7	66.9	164.2	116.5	55.8	93.5	17.1	87.0	65.2	80.0	119.1	47.3	847.8	66.4	70.8	168.7	138.9	56.4	119.5	81.6	95.1	66.8	340.4	40.2	64.7	111.8	98.4	65.3	72.4	89.7	39.2	87.9	60.9
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321211-22331484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 132.9;Late spermatids: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 89.1;U-937: 104.6"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	19.7	23.5	28.0	17.0	35.0	13.3	26.5	26.1	33.7	21.6	22.3	26.3	11.6	14.1	23.9	22.8	16.0	17.0	17.4	15.1	28.3	24.2	19.2	25.5	16.7	17.9	42.3	27.7	18.8	18.6	40.0	37.6	20.6	24.8	25.5	16.0	16.5	15.7	20.3	28.5	10.3	14.6	26.3	34.8	24.6	16.5	24.3	40.7	12.9	17.6	10.6	18.8	21.5	25.9	5.0	1.8	13.0	3.4	6.2	8.4	2.4	13.0	6.3	7.3	2.2	12.8	10.3	7.3	8.8	4.0	6.7	8.0	6.6	16.3	6.7	6.0	8.0	7.5	4.6	10.5	6.2	8.4	89.1	13.1	18.4	5.4	7.4	7.6	6.8	10.2	6.6	10.9	7.4	8.2	8.5	4.7	10.8	18.2	11.3	8.9	5.2	18.2	2.0	1.7	6.1	15.1	13.6	10.4	6.4	6.4	4.2	6.1	12.1	5.8	7.6	9.8	3.3	6.9	27.3	10.1	7.5	22.7	18.1	11.8	14.0	18.2	14.7	10.7	104.6	4.9	13.0	1.5	2.5	6.1	3.4	8.4	5.0	6.4	5.8	1.0	2.6	5.5	5.2	0.6	6.2	2.1	1.8	4.3	2.4	28.0	35.0	26.1	33.7	28.3	24.2	42.3	27.7	24.8	40.7	23.8	20.0	13.4	18.4	14.2	21.3	16.1	10.2	16.0	25.0	12.2	7.9	10.9	11.6	14.2	132.9	25.3	4.2	0.0	15.8	17.8	14.4	26.4	11.5	25.2	8.6	28.6	12.7	28.3	19.0	118.0	33.4	13.9	35.4	17.2	12.0	12.6	17.8	5.8	34.3	7.6	13.9	19.4	37.7	10.4	24.3	12.8	5.6	18.3	9.5	17.6
BOP1	KIAA0124	ENSG00000261236	"Block of proliferation 1"	Q14137	8	144262102-144291370	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	4.8	4.3	5.7	7.7	5.9	7.8	6.4	6.3	6.9	2.0	3.9	1.6	2.0	5.1	2.7	1.5	6.8	2.6	4.8	5.1	5.5		2.8	6.2	2.3	6.6	4.1	6.7	2.7	17.5	5.1	2.2	3.2	4.3	2.9	1.5	1.5	5.8	3.0	19.0	7.4	4.5	4.9	2.0	4.8	4.4	8.3	3.3	6.3	3.9	6.7	4.5	3.5	6.9	5.2	6.4	2.5	4.7	3.5	5.7	2.5	12.5	24.6	3.4	14.5	2.0	2.3	12.6	8.7	1.8	8.8	5.5	18.6	7.3	15.3	14.9	3.3	3.3	10.1	6.2	10.3	2.0	13.4	24.8	19.2	14.9	14.1	4.6	8.5	10.6	4.5	5.1	7.4	6.7	1.7	5.5	14.2	19.3	5.1	3.4	32.0	22.8	10.9	8.3	12.9	67.8	17.5	5.1	23.3	3.6	8.4	19.1	7.6	9.3	12.1	5.9	1.7	8.9	8.1	10.3	8.1	25.0	10.9	24.9	4.9	3.1	12.8	6.0	13.8	10.6	0.0	4.7	2.5	4.4	4.7	4.8	5.2	4.9	5.7	6.4	4.5	4.4	4.1	0.2	3.5	4.0	4.1	4.2	2.5											8.9	6.1	13.4	13.8	0.5	10.2	6.7	10.2	2.7	6.8	10.4	0.0	21.5	5.0	24.4	8.9	8.7	7.0	0.0	18.7	35.1	9.3	10.0	10.3	13.1	19.1	14.3	25.8	3.7	6.4	15.5	9.8	7.5	0.0	11.8	9.2	13.7	20.3	8.6	9.2	13.6	4.2	12.9	4.3	10.4	60.5	0.1	14.9	8.7	21.6	11.6
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921188-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	11.5	13.4	6.0	11.5	7.2	6.0	17.5	5.0	8.9	7.8	7.9	4.6	5.3	4.0	11.0	5.4	11.7	9.3	10.0	17.6	5.9	6.8	8.0	18.6	7.1	7.4	5.8	6.5	11.8	15.9	10.6	5.4	11.3	7.4	8.0	6.8	4.8	9.6	7.9	31.7	9.2	5.0	12.6	6.3	9.9	7.3	8.9	4.6	20.1	7.1	11.9	12.9	7.3	10.1	4.0	9.3	0.9	3.4	4.5	5.5	2.2	11.9	14.8	8.2	11.6	6.1	6.9	16.8	12.2	6.4	19.3	14.1	20.4	3.1	22.0	11.1	9.1	13.2	7.9	24.9	17.8	15.2	7.9	27.1	20.5	10.4	22.9	10.6	14.6	9.0	8.9	11.6	18.0	16.4	4.2	13.2	12.9	26.0	4.9	12.7	20.4	15.3	14.7	6.4	37.3	15.6	18.3	11.2	14.0	10.7	10.2	16.5	10.0	8.1	7.4	14.2	6.6	8.6	12.9	10.2	11.2	13.3	7.6	17.7	5.7	7.4	47.6	3.8	14.8	11.7	0.0	3.4	0.9	3.9	3.4	5.5	3.8	2.5	3.1	5.4	4.0	1.3	3.0	0.3	4.5	3.1	9.3	3.1	2.2	6.0	7.2	5.0	8.9	5.9	6.8	5.8	6.5	7.4	4.6	0.0	3.8	8.9	21.5	27.5	2.5	2.5	5.1	4.0	5.7	1.8	3.9	19.5	3.3	20.9	6.2	7.1	1.4	0.0	14.8	19.5	10.6	9.6	2.3	6.6	10.6	0.0	5.2	4.3	1.0	3.4	7.5	5.3	8.5	7.2	5.5	3.4	18.6	0.0	6.7	8.4	2.8	6.5	17.3	6.5	26.9	22.1	24.4	5.0	9.9	23.5
C16orf58	FLJ13868	ENSG00000140688	"Chromosome 16 open reading frame 58"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	13.5	17.7	15.9	15.3	22.3	11.0	15.7	17.9	30.8	22.6	17.5	16.6	34.2	18.6	24.2	21.4	16.8	21.0	20.0	16.7	12.9	15.3	19.1	51.0	13.9	15.7	13.8	16.4	29.5	49.1	30.7	27.6	23.1	13.1	22.0	11.6	22.9	36.9	26.7	4.8	14.1	22.2	15.6	9.1	12.9	19.7	11.9	14.3	15.1	26.4	14.2	19.3	15.9	17.4	8.9	12.0	8.8	9.8	10.8	11.3	8.4	11.6	15.4	9.7	16.8	22.5	15.0	18.0	14.0	23.9	10.9	13.0	4.6	20.5	10.0	29.7	20.6	14.1	16.3	9.6	12.9	5.1	14.5	9.6	10.1	8.8	11.6	32.7	11.9	12.2	18.2	14.1	14.3	29.5	21.5	10.5	16.1	14.9	17.3	10.6	22.0	5.5	8.0	7.5	17.1	10.1	12.7	14.5	30.2	12.4	7.3	10.6	16.3	10.5	27.7	21.8	9.6	23.9	17.6	9.1	19.1	10.7	12.2	9.1	25.2	14.7	7.5	24.4	18.4	26.2	3.8	6.9	8.8	10.3	9.8	9.6	8.9	10.7	10.2	12.0	8.5	10.8	9.3	1.2	10.8	9.6	11.0	11.3	8.4	15.9	22.3	17.9	30.8	12.9	15.3	13.8	16.4	13.1	14.3	6.0	14.2	9.0	7.9	5.5	22.6	0.8	10.2	6.7	9.1	15.7	2.0	18.1	5.0	17.5	1.5	6.3	17.7	0.0	18.6	17.9	13.1	13.9	18.4	21.9	12.9	12.7	14.3	7.4	8.4	2.5	20.1	6.4	16.9	6.4	20.7	12.4	12.0	10.5	15.2	6.8	22.3	25.8	9.2	13.4	11.7	4.1	18.7	8.3	17.8	7.9
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.1"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011044	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear membrane, Cytosol"	"HPA011044: AB_2668414"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	5.2	7.0	15.9	7.3	33.1	14.7	4.8	18.2	31.2	5.8	10.3	7.5	8.3	18.7	4.1	6.1	9.4	10.9	6.3	7.9	15.8	13.6	6.3	7.3	8.3	8.5	9.1	12.6	3.9	7.5	7.8	14.2	4.8	11.7	4.8	8.8	5.6	8.7	7.0	8.3	12.5	19.4	6.1	7.3	9.2	5.5	2.6	9.1	7.0	5.5	6.7	6.6	6.6	5.3	0.4	1.1	5.7	4.2	1.7	1.6	1.1	3.4	2.5	3.5	7.2	4.6	1.9	2.2	5.2	4.6	5.2	4.4	4.1	3.6	5.2	13.7	3.6	5.3	7.7	4.4	2.2	2.1	8.1	3.7	20.4	3.3	2.9	6.1	5.8	29.8	2.3	4.6	9.7	3.6	5.7	3.2	7.8	8.4	9.3	4.8	9.1	6.5	14.1	1.3	8.4	6.9	4.1	3.2	5.9	5.1	2.2	11.0	6.2	2.2	11.7	3.3	1.4	20.6	7.8	3.9	4.8	1.6	5.7	9.1	4.1	2.4	2.0	3.0	10.1	5.3	1.1	3.0	5.7	0.6	3.2	1.0	0.4	1.4	1.4	1.1	0.1	1.6	0.8	1.0	1.7	4.2	0.7	1.6	1.1	15.9	33.1	18.2	31.2	15.8	13.6	9.1	12.6	11.7	9.1	6.0	6.2	2.2	1.4	9.5	14.6	2.0	2.5	13.4	4.5	1.8	35.3	0.8	3.3	2.8	2.6	5.0	25.7	0.0	2.4	1.2	2.0	2.9	2.3	4.3	7.9	20.6	1.2	15.4	12.9	1.5	2.0	9.7	6.8	7.2	5.5	4.8	4.2	10.1	1.4	3.3	29.7	6.5	3.1	2.3	1.9	9.5	0.9	8.7	4.5	1.6
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85606654-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: AB_2681360"	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	10.7	9.8	7.0	17.4	12.3	11.5	16.5	16.6	9.9	16.5	15.2	17.2	17.7	13.1	17.1	15.0	13.6	14.3	16.2	13.7	7.7	6.6	13.5	16.8	17.5	15.6	16.1	7.2	22.2	25.4	13.3	14.6	21.8	11.4	16.5	14.1	10.8	20.6	20.6	23.3	18.6	18.5	14.8	10.9	17.5	13.4	15.1	12.3	37.1	17.2	20.4	17.6	15.2	17.0	15.4	16.5	36.1	22.7	19.2	20.1	9.5	8.6	8.1	13.3	10.0	13.7	6.8	9.0	4.0	5.3	6.7	8.9	7.3	10.6	11.8	6.1	7.3	6.2	9.6	7.3	8.0	7.2	6.2	15.3	20.2	11.9	7.6	11.3	10.8	10.7	10.4	9.3	5.0	13.3	9.7	10.9	13.2	10.2	13.3	6.4	9.9	12.3	10.6	6.4	10.6	7.0	13.8	25.4	11.6	8.6	9.2	17.1	12.3	6.2	8.3	8.0	8.2	9.4	5.5	6.4	4.8	13.3	5.4	3.8	17.2	12.0	11.0	7.1	11.0	5.8	18.0	22.7	36.1	15.4	15.0	14.5	10.9	14.7	14.5	16.5	15.4	20.1	18.7	36.1	19.2	16.9	10.6	11.9	9.5	7.0	12.3	16.6	9.9	7.7	6.6	16.1	7.2	11.4	12.3	59.6	76.5	21.4	16.8	5.3	17.5	9.3	38.2	25.4	34.2	33.2	33.4	38.5	14.9	14.0	3.3	9.0	23.5	0.0	17.1	14.2	11.3	12.3	32.5	19.2	20.3	23.8	18.5	19.0	31.3	7.0	22.5	24.2	13.5	14.4	15.8	10.8	17.3	10.5	12.7	19.2	23.7	19.4	7.6	37.2	20.6	8.5	20.8	28.0	16.8	17.6
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.4	6.6	15.4	10.7	6.0	8.7	6.7	5.9	9.7	6.0	8.7	4.7	13.3	8.8	5.0	18.5	12.4	8.7	6.2	4.4	5.1	12.6	4.9	5.9	9.2	12.6	11.8	15.9	6.9	9.3	5.8	6.1	5.2	10.6	14.4	12.9	10.1	5.7	18.8	10.2	24.4	13.0	5.6	12.5	20.9	5.2	11.2	6.3	9.8	8.6	16.0	6.5	21.7	9.0	7.1	9.9	17.8	7.6	8.1	26.6	8.8	14.6	12.3	12.1	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1	8.9	7.5	6.1	8.2	13.5	6.1	5.3	10.2	4.0	5.7	1.8	5.9	10.4	0.0	7.5	5.8	9.3	8.4	0.0	8.8	9.1	9.3	8.5	1.1	6.4	11.6	4.8	12.1	14.7	10.3	3.2	7.5	9.8	6.8	4.6	12.3	6.7	9.2	10.5	8.1	6.3	6.1	6.5	13.2	11.2	13.8	11.2	8.1	14.6	10.2	6.0
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039542, HPA040004"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			Nucleoli	"Nucleoplasm, Vesicles, Centrosome"	"HPA039542: , HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.3	3.7	1.0	0.3	1.9	1.4	0.1	0.7	0.2	2.0	2.2	0.0	1.7	0.3	3.3	0.5	0.8	0.8	0.0	1.6	1.4	1.2	0.6	1.5	0.6	0.0	0.0	0.2	0.0	0.6	1.0	1.7	0.3	12.1	0.2	1.3	0.3	0.6	2.6	0.0	1.8	1.4	0.5	0.0	0.5	0.0	0.0	0.2	2.6	0.0	2.1	1.0	0.2	0.1	1.2	0.2	1.2	0.5	0.8	1.9	0.8	0.4	0.3	0.2	0.0	0.0	1.6	0.0	1.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5	8.9	3.2	0.0	2.5	1.5	0.7	7.1	2.5	96.4	17.0	5.2	3.9	1.0	5.0	0.8	21.6	1.7	0.0	0.0	1.5	0.5	1.7	1.5	0.0	1.5	0.5	1.6	0.0	2.5	1.8	11.5	5.8	0.9	0.0	0.0	1.7	5.8	0.4	0.0	6.7	2.5	20.8	0.0	1.4	9.1	0.9	0.5	0.2	0.0	0.6	0.5
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	17.9	10.2	11.3	14.2	16.3	54.9	18.9	14.9	14.7	17.6	16.9	8.9	7.7	7.5	14.8	17.4	17.0	17.2	11.2	14.5	11.5	12.5	16.0	15.4	12.6	13.7	14.8	12.4	18.8	12.5	2.6	18.2	18.7	13.5	18.7	12.5	6.5	12.7	13.3	23.5	12.7	18.9	14.5	16.5	17.3	12.1	18.4	14.9	15.3	19.9	17.9	18.1	21.4	20.9	18.9	18.6	17.9	14.0	13.1	23.6	6.7	11.5	11.0	9.1	6.5	10.1	8.8	14.2	10.5	12.2	18.6	15.2	22.1	6.6	13.6	5.4	10.5	13.1	7.4	41.5	20.1	15.8	14.3	22.1	13.3	6.5	14.6	29.9	17.6	7.7	15.3	17.1	19.6	24.7	15.7	15.2	24.7	25.2	7.0	11.4	20.9	16.2	24.1	14.4	11.0	25.5	12.3	13.6	11.1	9.8	11.6	15.5	7.5	12.1	6.5	15.3	10.6	14.0	23.4	7.1	9.3	7.1	6.5	19.2	11.2	12.5	26.1	6.6	14.1	12.4	12.7	9.3	16.8	11.6	9.6	19.8	15.2	18.6	16.9	9.6	18.9	22.1	17.6	17.9	13.1	14.0	18.6	23.6	6.7	11.3	16.3	14.9	14.7	11.5	12.5	14.8	12.4	13.5	14.9	62.5	48.8	69.0	103.9	76.2	31.5	38.7	38.2	61.6	62.6	41.8	21.6	67.1	109.5	41.0	58.5	55.4	25.5	23.3	49.8	74.4	49.4	61.8	76.2	47.2	50.6	41.3	34.3	57.1	55.3	15.9	49.5	60.8	45.5	44.1	52.3	38.3	47.8	48.0	50.5	57.2	38.9	19.4	54.7	185.8	116.5	78.5	122.8	77.6	53.2	81.7
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842071-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 200.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	13.5	12.4	7.3	8.6	11.0	6.1	11.2	3.3	11.2	5.8	6.7	7.9	3.4	7.4	8.4	5.0	9.3	7.4	8.3	9.3	6.7	6.4	8.1	11.4	5.4	8.2	10.0	6.0	11.3	13.6	200.8	12.7	7.3	8.5	11.9	4.7	6.7	6.4	6.2	20.2	10.4	6.2	7.3	6.7	9.3	7.7	47.8	8.7	10.2	7.9	12.6	6.5	8.6	6.5	6.9	20.0	5.0	19.5	4.2	8.5	6.7	21.0	28.7	7.1	20.5	5.8	9.6	9.7	14.2	11.1	26.1	14.0	24.4	14.2	25.8	27.2	7.7	18.6	19.8	24.0	17.1	12.0	9.1	26.6	13.1	12.7	34.0	19.2	20.5	22.5	10.9	13.0	24.1	15.3	3.8	19.3	14.2	41.9	13.3	12.7	24.9	30.8	31.3	28.7	12.5	41.3	21.0	10.7	64.9	9.1	9.0	16.1	10.4	9.1	21.1	16.6	4.7	21.3	8.2	12.6	26.0	16.0	35.3	30.7	11.2	16.5	27.9	21.3	22.2	31.4	2.6	9.1	5.0	6.5	19.5	6.9	6.9	6.9	6.0	20.0	6.5	8.5	7.4	0.7	4.2	6.3	11.2	6.2	6.7	7.3	11.0	3.3	11.2	6.7	6.4	10.0	6.0	8.5	8.7	0.0	2.1	3.0	15.4	32.7	9.3	0.4	2.5	0.0	4.5	1.8	7.9	15.9	6.6	20.4	19.7	6.8	2.6	0.0	10.4	14.1	9.5	18.2	4.7	2.4	16.0	3.2	6.9	3.7	2.8	10.6	10.6	7.9	15.1	4.6	4.9	3.6	13.7	3.5	5.6	5.4	7.9	19.4	20.2	37.1	19.1	27.0	6.9	6.1	9.7	15.5
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.5	11.1	14.6	13.0	13.4	11.8	9.8	5.5	18.0	24.4	20.2	15.8	9.1	13.9	10.0	8.6	14.4	7.4	20.2	128.1	18.5	6.8	9.3	13.0	7.5	11.1	15.7	14.7	9.0	11.6	9.4	14.9	17.2	16.6	15.6	13.3	13.8	12.0	141.4	13.9	14.1	12.0	17.2	10.0	11.2	12.6	445.0	12.9	7.6	15.1	13.3	12.4	9.8	7.4	14.7	10.5	9.8	17.9	7.1	11.4	10.8	12.9	11.1	6.0	9.7	21.4	10.5	13.7	13.7	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5	20.8	25.0	32.0	62.9	79.7	15.3	0.5	48.4	4.0	23.9	45.4	9.8	64.6	59.7	71.7	10.1	44.2	11.3	23.3	53.6	108.9	77.4	41.8	68.1	32.1	111.7	17.5	43.8	34.4	23.2	6.8	59.2	34.0	50.6	54.1	33.5	51.3	55.4	7.0	59.4	66.3	15.3	32.3	54.2	25.9	40.3	75.3	39.1	34.1	78.3	32.5
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.5	6.7	10.8	11.5	3.0	2.8	21.3	6.9	3.2	9.5	10.2	8.6	12.7	12.9	9.4	2.8	5.2	12.0	12.1	5.7	9.6	9.4	10.5	18.2	13.2	9.1	3.1	16.6	20.2	1.4	5.7	8.0	5.8	4.5	4.2	17.5	24.5	18.0	7.0	4.9	15.9	20.2	10.5	6.7	11.2	16.3	12.6	12.0	4.8	2.1	18.4	8.5	9.7	8.1	8.0	6.2	7.4	11.9	4.9	7.8	13.0	9.1	10.6	14.2	20.7	16.1	4.8	29.3	14.7	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5	0.0	2.1	0.0	4.2	6.2	9.6	26.8	2.5	1.4	4.5	5.2	11.8	2.0	6.6	1.7	0.8	1.8	3.9	0.0	1.1	3.6	2.1	2.2	2.3	2.5	4.3	0.0	1.7	1.8	5.2	2.3	1.4	4.0	1.7	4.6	3.1	1.3	2.1	3.4	0.4	0.8	10.1	0.0	1.0	43.5	37.7	5.4	34.9	3.5	4.7	3.2
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 89.5;Spermatocytes: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		460000	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	13.7	25.5	20.6	11.5	25.7	18.6	12.5	34.6	32.9	11.3	14.6	16.5	7.3	10.2	13.7	10.4	11.7	9.5	10.1	16.6	19.2	19.3	9.7	37.7	8.5	14.1	18.8	21.1	23.8	7.9	20.0	20.8	13.8	33.0	13.5	15.0	9.1	8.7	12.0	26.3	10.7	9.9	16.1	22.5	8.8	12.9	25.4	22.2	28.6	8.0	10.8	14.7	12.6	9.7	8.6	8.4	6.0	8.7	11.7	10.0	3.6	26.4	25.6	55.0	23.5	13.0	20.5	12.8	30.4	18.5	28.9	30.8	20.8	9.0	28.9	10.7	20.4	31.0	30.1	39.4	17.2	36.4	26.0	30.1	48.2	20.5	20.0	9.7	36.7	20.2	10.4	9.2	16.2	35.2	15.1	21.8	25.4	34.0	27.1	23.9	18.2	31.2	9.5	29.5	19.7	20.6	33.1	58.5	25.3	9.3	16.3	25.6	21.8	41.3	14.8	15.1	25.4	27.3	10.0	18.7	28.1	24.9	47.7	44.8	15.4	33.2	41.6	17.6	17.4	27.5	5.4	5.7	6.0	9.0	8.7	8.8	8.6	6.7	10.0	8.4	8.0	8.2	8.5	0.9	11.7	7.8	5.4	7.5	3.6	20.6	25.7	34.6	31.2	19.2	19.3	18.8	21.1	33.0	22.2	23.8	20.5	16.4	7.9	7.6	18.2	57.6	10.2	33.5	21.6	8.7	35.3	13.2	8.3	10.6	89.5	13.5	8.1	0.0	6.6	12.2	13.2	11.2	35.9	6.2	16.0	12.7	11.6	14.1	12.9	37.9	18.1	13.5	6.8	16.2	14.1	14.9	12.6	12.4	27.3	8.7	24.2	19.4	6.6	81.4	60.7	10.2	9.6	9.6	14.9	7.8
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog (yeast)"	Q9BQ75	3	99817834-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	21.4	34.1	23.7	15.1	24.5	17.7	20.6	24.1	27.4	13.4	12.9	9.4	8.2	8.3	19.6	10.7	12.0	13.3	10.5	16.6	24.0	22.2	17.1	17.5	10.8	15.8	15.3	22.3	21.1	26.4	20.7	25.9	11.7	19.2	15.1	12.4	9.3	12.4	14.5	58.2	11.5	9.3	13.8	15.7	12.9	11.0	28.1	13.5	13.6	14.9	14.4	14.7	18.8	15.7	23.5	26.1	1.6	10.9	11.2	19.0	7.9	28.9	13.1	13.0	18.7	9.2	10.9	13.4	13.5	7.3	24.3	20.3	16.3	9.7	31.4	23.7	7.2	21.5	17.5	18.0	15.3	32.2	16.2	17.2	24.7	9.3	13.2	16.6	33.8	13.6	7.4	14.9	18.1	30.3	7.7	16.8	25.4	15.2	20.4	17.6	20.0	27.0	31.5	19.0	27.6	32.9	12.2	21.0	33.6	15.0	7.1	36.7	15.4	13.5	11.0	30.7	13.0	13.3	21.2	4.8	19.3	54.8	11.2	27.4	14.6	29.0	61.0	12.5	37.4	32.2	0.3	4.7	0.8	10.0	10.9	14.2	23.2	14.8	13.5	9.9	23.5	18.7	19.0	1.6	11.2	9.7	26.1	13.7	7.9	23.7	24.5	24.1	27.4	24.0	22.2	15.3	22.3	19.2	13.5	6.0	14.2	29.8	33.2	55.3	30.0	40.3	43.3	29.4	23.9	59.3	17.7	34.3	82.9	17.0	137.8	37.9	1.1	0.0	40.8	46.0	41.2	21.8	61.1	44.9	24.7	120.8	14.5	19.0	5.8	151.1	46.9	25.2	35.4	14.4	13.3	17.6	29.9	0.0	55.2	66.2	21.4	25.8	64.6	105.9	127.7	57.7	18.3	28.7	20.7	22.0
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938187-56961054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.8"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 199.1;Late spermatids: 405.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	8.7	5.6	7.3	5.5	8.1	10.9	8.2	12.6	8.9	8.9	6.4	7.6	4.9	6.7	8.1	8.1	8.5	6.8	4.9	5.3	5.8	5.7	7.0	8.5	5.3	7.7	7.1	6.5	8.6	9.1	8.5	9.7	9.5	8.2	7.8	7.3	5.8	7.5	9.1	7.9	7.8	7.0	5.9	7.2	8.1	6.4	58.8	6.0	12.3	8.7	5.3	8.5	7.7	7.3	22.5	13.7	14.0	13.4	12.7	17.8	8.6	13.2	10.1	20.8	8.0	7.1	8.6	14.4	9.5	9.0	14.6	15.6	13.8	11.5	16.0	19.4	7.6	10.9	7.8	14.1	11.0	20.9	19.2	17.8	26.1	9.7	15.6	7.7	21.9	16.0	7.9	13.8	11.0	11.9	8.7	12.4	9.5	22.5	13.4	13.7	16.8	17.2	14.0	12.2	14.7	10.2	8.2	25.6	12.8	10.0	13.4	17.7	17.5	6.4	6.4	16.0	12.5	23.1	21.5	8.7	17.0	12.9	8.2	12.3	19.9	24.8	18.8	8.9	12.2	10.3	14.0	11.5	13.9	13.9	10.4	15.6	22.5	15.4	14.6	11.3	21.6	17.8	17.2	6.8	12.7	13.4	13.7	15.2	8.6	7.3	8.1	12.6	8.9	5.8	5.7	7.1	6.5	8.2	6.0	11.9	15.2	21.2	34.1	16.7	35.0	13.4	17.8	20.1	25.0	14.0	35.3	36.2	11.6	24.9	199.1	26.3	12.6	0.0	24.1	27.5	24.2	25.8	21.9	21.5	19.3	23.8	23.0	21.5	14.0	405.7	39.1	13.9	3.3	14.4	16.2	26.1	21.4	17.5	28.7	18.7	47.6	12.9	18.4	95.4	43.3	19.8	24.4	22.3	20.7	27.1
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 20.9"									"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				8.5	12.4	4.5	6.6	9.1	2.8	6.9	5.1	8.5	9.7	11.9	4.7	8.3	4.9	4.0	5.9	9.4	8.3	4.3	14.3	4.7	4.1	5.5	6.9	8.0	5.0	6.6	4.7	4.3	11.4	5.7	8.7	4.7	5.7	5.0	2.8	4.2	8.3	14.6	22.8	4.8	7.6	7.0	7.3	7.3	7.6	23.4	6.6	12.3	3.7	7.6	6.4	12.0	5.4	25.0	30.3	25.7	25.8	18.8	21.6	26.6	3.6	13.1	4.6	0.5	5.3	3.6	0.7	3.7	4.1	2.0	5.2	7.2	1.4	1.8	5.5	12.4	9.8	1.7	4.9	8.0	0.6	14.5	1.6	5.0	2.7	3.2	16.3	0.4	2.3	6.4	4.5	7.2	3.8	8.0	5.1	20.9	1.0	5.1	0.6	3.5	14.9	0.5	0.5	8.6	4.1	4.2	5.1	4.0	2.0	4.5	0.4	1.6	7.1	1.7	1.5	1.4	3.2	3.6	6.7	1.6	5.1	0.3	1.0	11.1	13.4	5.9	2.5	11.1	1.6	25.7	25.8	17.2	15.1	23.5	16.6	25.0	16.1	14.7	30.3	21.9	11.0	12.2	3.8	18.8	17.8	29.2	21.6	26.6	4.5	9.1	5.1	8.5	4.7	4.1	6.6	4.7	5.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.6	12.3	8.5	11.0	32.7	25.5	6.9	16.7	24.9	14.0	15.8	7.9	11.9	9.5	11.1	20.3	8.5	26.8	18.2	17.7	25.2	10.1	14.3	1.5	9.0	9.4	11.3	0.8	0.8	17.3	19.2	15.5	20.6	22.6	17.1	4.9	8.5	18.3	17.2	13.4	16.6	0.5	3.2	28.7	17.8	7.9	7.7	44.4	18.1	24.9	18.0	14.1	14.6	66.7	10.5	10.2	25.4	2.6	18.2	12.5	12.2	16.6	12.9	13.2	15.8	2.6	18.0	3.6	11.5	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1	128.1	76.8	40.4	87.4	72.7	16.8	108.0	79.0	77.6	69.4	66.3	13.7	59.5	84.6	63.4	1.1	55.4	37.1	23.3	72.9	45.8	62.4	110.2	8.1	86.6	42.9	42.9	48.1	57.7	74.2	2.2	79.4	49.0	50.6	32.5	53.7	70.1	62.4	52.6	82.4	99.4	16.5	58.2	55.6	3.0	10.0	79.5	65.2	47.5	69.8	73.5
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Cell type enhanced"	"Detected in many"	15	"Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.3	2.9	2.5	18.4	14.1	16.3	2.5	4.7	8.5	2.1	1.7	1.1	3.1	0.0	9.1	6.5	4.8	0.8	2.5	4.2	2.1	8.1	2.0	5.9	0.3	23.0	8.1	1.9	5.4	9.6	2.7	1.5	9.7	7.6	22.3	8.7	0.4	2.3	5.5	12.1	5.1	3.0	0.1	28.9	4.5	2.6	1.6	0.4	17.8	7.1	1.8	2.2	2.8	1.3	21.2	1.3	9.1	7.6	21.3	2.6	1.2	6.3	2.9	3.3	0.6	0.0	4.9	3.3	10.5	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4	6.0	6.4	19.9	13.2	9.2	5.0	9.8	48.4	10.7	6.8	73.3	11.8	18.1	411.1	21.5	2.6	23.7	181.3	0.0	27.8	9.4	16.4	23.5	24.3	272.9	59.4	1.6	8.7	49.1	76.7	2.9	24.2	36.1	35.4	11.8	69.9	93.7	32.1	152.6	22.6	848.9	10.8	19.4	12.3	0.9	0.2	8.2	17.4	15.3	78.8	12.2
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	25.3	22.8	21.3	21.7	15.5	18.0	16.0	18.9	14.5	18.0	18.5	22.4	24.8	35.3	32.4	19.8	17.8	19.1	28.8	24.2	34.9	33.6	20.5	48.7	13.7	25.4	17.7	19.9	21.0	14.6	16.7	26.5	44.1	11.3	24.9	24.3	32.7	15.5	27.3	20.6	37.8	21.0	32.6	71.8	35.6	24.6	25.9	36.3	26.2	21.2	27.2	25.8	11.8	18.5	21.4	19.6	28.6	13.7	16.4	18.3	29.5	23.6	25.3	17.1	29.8	49.9	24.7	43.6	23.4	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0	14.9	14.2	31.8	57.7	70.6	19.2	17.3	7.6	14.7	31.8	31.4	23.6	50.1	33.2	41.0	33.6	28.9	16.1	0.0	42.0	61.5	36.1	25.3	40.3	14.7	39.5	15.9	13.9	17.2	15.4	10.8	22.5	25.0	25.3	30.7	16.0	25.8	34.4	10.5	16.6	66.3	19.8	12.9	36.3	85.0	87.9	67.2	28.4	26.3	25.4	52.2
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 120.8;Late spermatids: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	9.6	11.2	9.7	8.5	16.7	7.0	10.4	11.9	16.4	14.1	9.4	9.9	9.8	4.2	13.9	17.1	8.4	11.2	9.5	9.3	9.6	11.0	11.2	7.2	7.9	9.2	8.9	9.5	13.2	9.5	18.9	17.9	11.2	13.1	10.5	9.2	11.6	7.8	14.2	11.5	11.1	6.9	11.8	7.7	9.9	7.9	27.7	8.3	13.9	11.8	8.1	11.1	10.5	8.3	7.1	5.2	1.7	10.1	3.3	6.0	4.2	16.9	13.6	15.3	11.5	10.1	12.4	12.5	11.8	11.7	11.2	11.1	10.9	5.2	5.0	11.9	12.0	12.7	8.8	17.2	13.1	18.5	20.5	12.7	9.7	9.2	14.9	9.1	10.2	5.6	11.8	7.9	14.5	9.1	7.9	14.9	3.7	12.4	7.1	12.1	12.4	10.2	9.4	19.0	7.3	8.1	5.1	20.2	9.8	10.3	6.5	12.6	18.6	11.8	12.2	13.8	11.2	8.6	5.6	11.5	11.2	13.0	8.5	12.7	7.4	8.3	2.1	8.7	7.1	7.4	1.7	10.1	1.7	4.5	6.9	6.0	5.7	4.0	3.5	5.2	7.1	4.8	3.0	0.5	3.3	8.0	1.7	3.3	4.2	9.7	16.7	11.9	16.4	9.6	11.0	8.9	9.5	13.1	8.3	3.0	7.5	8.2	2.2	2.4	23.0	5.9	5.1	28.1	13.6	22.7	53.0	6.0	0.0	6.9	120.8	4.3	1.6	23.3	6.4	5.8	5.6	1.6	10.4	5.7	6.1	17.5	11.3	9.2	13.6	273.7	14.7	9.5	1.7	5.4	5.5	11.2	6.9	3.5	13.1	4.9	28.3	0.0	3.9	15.2	6.4	2.3	2.4	6.9	5.1	1.3
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.6	8.8	16.1	21.0	11.9	15.8	16.0	18.7	7.1	14.5	15.4	14.2	15.6	30.1	17.2	13.9	15.7	11.4	10.8	11.1	18.4	21.3	18.9	20.6	11.5	11.8	14.3	16.9	15.9	13.7	9.0	14.1	13.8	14.4	12.6	19.8	20.9	13.9	14.8	14.7	24.9	26.1	15.5	6.5	18.5	16.1	16.2	41.5	13.1	13.5	18.0	15.8	16.0	15.0	16.0	12.0	12.1	15.9	13.9	10.0	10.4	14.2	25.6	18.4	19.1	27.1	15.2	30.5	14.8	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8	3.0	7.4	18.2	65.3	45.2	5.5	27.9	22.9	13.4	21.6	14.0	9.8	38.5	18.3	24.9	5.1	26.8	3.6	0.0	19.6	38.1	27.3	43.1	12.7	10.9	28.5	0.0	4.6	16.5	16.1	3.6	26.7	17.5	27.0	21.6	11.7	6.0	17.2	2.9	19.1	22.7	4.1	6.5	49.9	12.6	21.1	33.1	29.9	25.4	15.7	57.8
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 73.8;Late spermatids: 143.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	8.2	11.4	24.1	9.6	21.9	3.9	13.7	8.6	19.8	17.8	10.1	8.5	19.7	7.3	9.8	15.0	12.3	33.5	12.7	9.9	17.7	15.2	16.0	7.1	12.8	7.5	9.5	15.7	15.8	14.9	19.2	19.3	11.9	7.9	13.2	9.2	13.1	16.4	16.3	4.4	11.4	8.0	7.7	6.4	7.5	11.1	36.5	9.7	13.2	26.1	6.6	8.6	8.4	9.1	12.6	14.8	17.5	11.2	15.7	16.6	8.1	8.9	4.5	9.1	8.2	11.7	11.8	0.0	3.8	7.4	5.9	6.5	2.8	10.5	2.2	8.3	5.5	6.8	4.3	5.7	10.1	4.2	5.5	7.5	1.3	1.3	3.1	18.6	7.1	1.9	9.5	33.2	7.8	14.2	15.5	8.4	10.9	2.6	4.5	7.3	11.1	6.6	7.1	3.6	13.3	3.7	6.5	3.9	2.9	12.4	5.3	12.9	6.9	7.9	6.1	15.4	6.9	11.0	6.9	5.1	5.4	5.5	8.1	3.8	2.8	0.8	1.0	16.1	2.4	5.2	15.6	9.6	12.8	13.5	9.5	16.6	8.7	11.2	12.1	9.8	12.6	13.3	11.0	17.5	15.7	11.2	14.8	10.2	8.1	24.1	21.9	8.6	19.8	17.7	15.2	9.5	15.7	7.9	9.7	6.0	8.0	3.7	11.7	4.9	13.6	3.6	15.3	28.1	12.5	3.5	2.0	23.5	26.6	24.0	73.8	4.5	8.0	0.0	13.8	16.6	7.6	8.9	15.0	2.9	12.2	11.1	12.1	9.8	3.8	143.7	10.9	4.9	8.5	6.4	13.8	10.1	16.3	8.6	7.1	15.7	13.1	6.5	4.4	52.4	14.3	9.3	16.6	6.5	13.4	10.8
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	11.0	4.8	3.7	8.3	3.6	5.8	8.4	9.2	4.4	13.0	24.9	3.2	23.0	14.5	15.6	11.1	8.2	9.2	10.2	6.0	3.1	2.6	11.1	8.6	6.6	4.5	2.3	3.0	13.8	22.3	24.6	5.0	8.5	3.5	11.6	13.8	8.5	7.2	23.3	10.2	20.0	38.3	15.9	3.1	6.2	15.3	8.6	2.3	30.4	7.1	8.8	7.7	17.4	16.8	4.3	0.8	1.6	2.7	5.3	1.7	1.2	10.4	8.6	7.8	12.3	14.3	12.1	1.9	18.9	18.3	9.2	8.9	5.8	15.9	10.9	8.1	14.4	5.0	8.3	9.1	10.8	12.9	0.5	2.8	1.5	9.7	4.0	7.4	1.0	0.7	5.6	2.4	11.3	10.0	32.4	21.9	3.5	1.4	0.0	18.5	1.3	1.8	2.0	7.5	7.3	5.2	2.2	8.0	0.5	15.6	9.1	1.3	1.8	3.1	0.8	2.3	11.3	0.6	1.0	26.3	6.9	6.6	5.5	12.3	0.9	0.6	15.3	6.5	3.4	5.1	0.0	1.8	0.4	1.7	2.7	1.6	3.0	0.4	1.2	0.8	4.3	0.4	0.8	1.6	5.3	2.7	0.6	0.0	1.2	3.7	3.6	9.2	4.4	3.1	2.6	2.3	3.0	3.5	2.3	8.9	8.3	4.9	7.1	31.1	6.5	5.2	12.7	26.8	14.8	12.2	33.4	6.4	3.3	6.0	1.0	10.8	34.6	0.0	12.4	1.0	11.3	5.5	2.3	13.1	4.1	12.7	3.5	9.2	12.7	2.5	12.7	7.5	3.3	0.0	25.4	3.3	13.5	23.0	8.5	2.9	24.9	0.0	8.2	2.1	8.5	39.9	3.1	1.5	22.8	17.8
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791937-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Group enriched"	"Detected in all"	7	"dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6"	"Cell line enhanced"	"Detected in all"		"PC-3: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	15.2	16.3	15.8	19.0	18.0	31.6	16.0	15.5	19.9	16.4	24.2	15.4	20.5	14.0	23.3	21.3	18.8	20.6	18.6	20.6	14.6	15.3	15.6	18.7	18.2	17.7	14.5	17.6	20.1	24.1	18.2	17.8	18.3	15.1	23.5	32.0	16.1	21.0	21.6	45.0	21.8	19.6	32.6	13.8	21.2	20.7	36.9	11.8	25.2	21.1	19.4	21.7	30.1	16.1	3.2	14.2	41.0	16.6	1.0	3.4	4.5	20.4	10.9	11.3	10.7	8.7	9.4	11.8	7.7	12.5	25.0	22.7	34.5	33.6	8.5	25.3	11.2	39.9	15.5	9.9	16.5	16.6	4.6	12.4	9.2	11.5	22.0	17.7	18.0	15.4	9.4	15.6	16.3	15.8	11.5	14.6	12.4	8.5	8.7	14.8	27.2	14.7	27.9	7.6	11.6	74.6	11.9	14.0	8.8	12.5	9.8	10.6	9.6	15.7	12.8	16.1	9.2	12.7	28.9	8.5	15.0	11.2	14.5	18.4	9.5	6.1	10.5	32.8	11.6	12.8	4.8	16.6	21.6	1.4	6.9	1.4	3.2	1.9	2.4	14.2	2.7	3.4	1.6	41.0	1.0	4.2	5.5	2.7	4.5	15.8	18.0	15.5	19.9	14.6	15.3	14.5	17.6	15.1	11.8	14.9	18.5	22.9	37.2	22.7	18.5	17.9	12.7	24.1	21.6	24.4	3.9	56.0	43.1	57.6	31.1	21.1	32.8	0.0	66.5	35.6	23.6	31.5	5.8	16.8	62.7	19.1	21.4	22.7	26.5	10.6	26.2	33.7	15.1	86.6	70.1	42.1	70.4	51.8	25.5	33.4	24.1	0.0	24.5	77.5	33.7	24.1	48.3	18.1	31.6	54.5
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.7	4.1	3.3	3.4	5.0	2.3	0.4	4.5	0.8	1.3	0.0	0.0	0.3	3.4	1.0	0.9	0.2	0.6	3.9	3.5	1.2	6.7	0.1	2.8	5.7	2.4	0.5	0.2	2.6	0.4	19.2	9.9	1.2	36.4	1.6	0.0	10.3	1.7	0.4	0.8	0.2	2.2	0.5	7.0	0.2	3.0	1.6	2.8	0.1	0.9	3.2	2.5	2.1	2.5	3.8	0.3	0.1	31.4	3.2	1.5	6.1	1.3	0.4	0.1	0.3	0.3	0.8	7.1	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8	44.7	5.0	0.5	3.6	4.6	26.2	11.6	2.5	12.0	21.6	3.5	21.6	0.2	0.0	1.4	2.4	32.2	0.7	0.0	0.3	0.2	6.0	9.4	2.3	14.9	13.6	89.0	10.5	40.5	15.6	1.1	5.2	17.3	8.5	8.2	0.7	4.4	1.0	9.9	7.8	1.1	10.3	12.9	3.3	0.7	1.7	2.4	0.0	0.0	0.8	1.6
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"	"Group enriched"	"Detected in some"	4	"HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.2	1.1	1.0	1.4	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	2.1	0.0	5.1	0.7	0.0	0.3
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 4.1;Late spermatids: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4"									HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.7	0.0	8.0	10.4	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	20.0	12.9	40.1	14.7	37.2	35.9	22.7	35.2	27.5	29.7	32.4	22.4	20.0	18.4	31.0	41.8	40.7	20.4	31.5	33.8	39.0	6.9	14.2	16.1	16.6	25.3	18.6	18.3	17.3	27.8	32.2	36.7	23.7	41.6	52.0	18.0	25.3	5.1	58.6	12.6	15.6	14.9	18.5	29.5	13.2	15.8	36.1	13.3	39.5	32.3	25.1	28.3	19.5	15.7	20.9	31.9	15.3	17.9	56.3	45.3	22.5	18.0	21.0	6.3	12.0	14.9	30.8	14.9	33.1	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2	184.6	55.8	68.6	52.1	45.0	68.0	67.4	196.1	111.1	96.7	160.5	60.9	85.6	111.0	177.4	58.5	118.7	140.2	70.0	139.8	89.1	77.0	39.2	96.2	130.7	90.2	76.3	80.9	188.4	142.1	30.8	119.0	94.7	33.7	151.5	111.3	91.1	161.5	106.7	129.7	165.2	120.2	109.9	79.3	209.8	92.5	52.4	96.7	52.4	94.0	47.0
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.0	5.1	6.7	4.3	7.1	10.6	3.4	3.9	4.3	6.8	8.4	1.6	4.8	4.3	9.4	2.2	13.9	5.6	5.7	3.7	8.2	7.9	4.0	3.4	9.5	3.5	4.5	4.7	3.1	5.7	9.2	8.0	5.4	10.8	5.7	7.9	4.3	7.0	4.4	1.3	9.0	3.2	2.9	4.2	5.1	5.8	10.1	4.2	10.4	3.2	14.4	5.5	7.5	4.2	9.6	9.4	4.3	3.4	1.5	3.8	3.4	11.4	3.7	4.7	8.1	4.9	7.0	3.4	5.6	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2	11.9	2.6	2.9	5.2	2.7	8.3	6.2	0.0	25.4	4.5	5.2	3.9	2.9	6.6	2.9	17.3	2.1	0.5	0.0	0.6	1.6	3.0	1.5	2.3	0.8	2.1	0.0	1.7	2.5	2.4	3.2	10.0	1.1	1.7	1.8	1.4	5.8	1.1	0.0	12.7	4.6	10.5	25.8	2.3	58.1	17.7	1.9	1.0	1.3	1.7	0.7
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 429.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.7	7.7	10.8	10.4	6.9	5.7	11.7	6.6	6.7	9.9	8.4	8.7	11.1	13.2	11.0	5.3	6.2	11.9	8.7	14.7	7.3	22.8	12.1	18.9	10.9	6.6	4.6	15.2	24.4	4.5	9.1	10.3	13.2	5.5	9.3	10.5	14.4	27.8	6.6	31.8	15.0	12.4	21.6	17.4	9.6	14.6	9.0	16.4	13.0	13.0	16.2	10.2	9.4	19.8	10.3	9.5	27.1	22.4	9.8	7.4	13.7	8.8	17.1	15.6	22.7	429.6	10.2	17.7	9.7	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3	38.7	144.0	138.7	185.4	169.1	60.1	89.1	79.0	109.7	114.9	78.5	43.2	247.9	215.5	139.6	6.0	100.3	151.4	46.7	132.7	150.0	85.0	114.8	218.3	71.0	175.6	63.5	125.5	52.8	77.7	11.1	79.7	128.3	97.8	625.8	119.8	57.9	90.7	136.8	97.9	148.1	46.3	71.1	92.7	22.2	27.4	250.8	320.0	133.9	128.5	226.6
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.8	14.7	20.4	20.1	23.9	25.0	7.1	13.1	21.9	11.9	15.7	8.5	25.2	13.4	9.5	24.6	17.5	11.4	10.9	17.9	19.8	20.4	13.1	10.8	15.5	8.9	26.3	14.2	11.8	24.3	22.4	17.0	31.5	26.4	20.3	17.8	15.5	13.4	22.1	11.7	25.8	15.7	15.3	21.5	13.8	11.5	18.1	24.1	19.2	16.0	15.9	25.1	19.7	18.2	21.1	24.0	12.0	13.4	22.0	13.3	7.0	14.0	14.3	21.3	13.0	13.0	39.3	16.7	20.2	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3	20.8	21.1	11.9	14.2	16.8	35.3	24.9	7.6	18.7	15.9	14.0	88.4	13.6	3.3	12.9	23.1	21.5	15.8	0.0	15.7	13.8	11.9	17.0	8.1	14.4	15.6	47.7	16.7	24.5	30.4	20.6	16.1	18.0	13.5	12.6	21.4	20.6	13.9	17.5	17.7	13.3	229.7	12.9	10.8	18.1	12.6	14.9	9.4	20.8	18.4	16.9
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099881	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	28.2	21.8	30.4	22.1	31.9	30.8	27.9	58.8	34.7	24.8	22.0	31.9	22.4	18.5	27.0	22.9	27.6	22.7	18.3	18.3	27.8	16.2	22.4	18.2	20.8	26.0	31.5	26.3	31.2	24.2	23.1	32.1	23.5	24.3	22.1	25.9	20.4	24.6	20.5	27.3	33.2	22.7	25.6	23.2	26.0	25.2	20.3	32.7	28.2	20.8	12.5	29.9	23.6	24.6	21.0	21.6	24.8	26.4	27.5	25.9	22.3	23.4	15.0	31.5	12.1	16.8	18.6	18.0	23.2	17.1	40.9	37.2	22.1	34.4	23.7	15.1	22.0	18.2	23.4	34.8	25.9	37.6	26.5	34.8	34.4	29.5	22.4	16.5	27.9	27.4	14.6	22.4	40.1	23.7	15.3	25.4	21.2	36.1	21.9	22.5	13.2	27.4	25.8	20.8	18.0	18.0	28.3	26.8	20.7	24.0	12.0	20.3	19.9	25.0	21.7	27.8	23.1	18.9	25.8	23.0	21.9	22.7	19.6	27.1	13.3	20.8	46.9	22.3	41.7	26.2	24.8	18.2	14.6	22.2	23.4	25.9	21.0	23.1	22.1	21.6	19.9	19.8	22.0	3.6	27.5	26.4	11.0	21.8	22.3	30.4	31.9	58.8	34.7	27.8	16.2	31.5	26.3	24.3	32.7	26.8	16.5	14.1	12.2	11.7	15.3	5.6	10.2	32.1	35.2	5.2	45.2	23.7	8.3	21.4	12.5	17.4	11.3	0.0	27.7	27.8	14.3	7.5	18.6	8.1	21.3	20.6	8.6	12.9	13.8	5.4	27.3	19.0	11.8	23.4	14.7	5.6	24.4	11.9	21.5	6.7	34.8	12.9	11.3	20.9	22.8	11.7	19.0	16.2	16.2	8.0
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.7	9.3	17.8	5.0	0.9	1.4	46.0	8.0	3.6	11.5	9.4	6.9	8.7	17.1	3.8	2.6	9.5	7.6	18.3	6.2	11.5	8.1	12.4	23.3	14.3	6.6	0.1	17.3	14.6	0.4	1.0	13.0	7.2	1.6	6.9	14.7	14.2	19.6	8.7	10.0	14.4	6.7	21.4	6.7	6.5	15.8	14.5	12.1	4.0	9.8	4.9	9.8	9.8	7.7	3.1	13.5	11.8	11.0	4.0	9.6	11.0	5.8	11.6	8.3	16.3	28.9	5.5	17.8	16.3	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6	0.0	0.3	9.7	2.8	4.0	2.8	1.6	0.0	1.4	1.2	1.8	9.8	6.6	0.0	1.6	4.4	1.5	0.7	46.7	2.9	12.7	1.3	2.2	1.1	1.0	5.0	0.0	1.2	3.7	3.4	5.6	2.0	5.2	3.3	7.2	2.0	0.8	1.4	2.8	1.4	0.5	5.8	19.4	0.8	55.1	32.4	2.4	5.8	3.8	5.0	2.3
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	31.7	23.4	28.7	12.0	25.3	8.1	18.6	20.1	31.2	18.3	17.2	28.0	6.0	13.1	20.4	13.1	20.4	13.1	14.6	28.5	26.1	22.6	21.4	18.4	16.5	13.1	27.6	21.6	18.3	6.8	14.2	8.5	29.6	29.3	15.6	18.4	19.0	9.7	22.1	51.0	9.1	18.7	26.9	33.8	17.8	12.2	12.6	25.4	9.4	14.8	12.2	12.1	15.5	13.5	1.7	13.6	4.7	3.5	3.1	1.5	0.7	15.6	9.4	12.8	5.4	25.4	33.6	10.1	39.8	20.4	24.4	15.5	6.5	5.1	9.7	24.5	51.5	10.7	6.2	10.8	13.7	26.7	2.2	5.9	7.9	3.3	10.8	12.2	7.9	2.0	32.2	11.8	15.0	18.1	16.7	34.9	2.3	8.5	3.0	45.1	5.5	4.8	6.8	6.7	9.0	14.8	3.2	11.6	3.3	19.4	15.3	0.3	11.7	9.8	8.1	9.5	15.0	2.8	9.8	40.5	15.3	8.1	8.4	23.1	2.3	2.7	6.6	15.2	5.5	21.5	2.4	3.5	4.7	1.5	3.3	1.0	1.7	1.1	0.8	3.6	1.0	1.3	0.5	4.0	3.1	1.9	13.6	1.3	0.7	28.7	25.3	20.1	28.8	26.1	22.6	27.6	21.6	29.3	25.4	50.6	29.1	13.8	81.0	27.8	33.3	36.3	12.7	30.8	70.5	55.8	43.2	85.1	48.0	58.2	4.3	78.7	55.8	0.0	26.7	74.7	58.7	87.3	23.1	32.1	80.7	20.6	23.1	93.3	74.8	4.9	50.3	60.5	54.0	36.9	29.6	75.8	51.7	37.4	62.2	31.6	34.6	58.2	52.3	13.0	27.6	28.1	150.6	28.0	32.6	117.0
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.5	29.0	22.5	20.7	3.4	4.5	28.7	18.7	18.4	37.9	34.4	36.6	25.6	18.5	4.0	26.7	43.1	22.2	33.7	17.1	37.2	34.5	18.0	20.8	27.8	15.6	0.5	16.7	17.1	2.3	1.9	35.2	24.8	9.0	26.7	21.2	11.6	41.5	29.8	26.8	22.7	7.9	49.7	29.7	21.7	16.5	34.2	9.6	8.9	18.3	12.7	20.1	23.9	20.1	10.9	44.4	19.6	18.7	10.7	30.8	46.8	35.9	64.8	5.5	9.1	26.8	14.3	16.1	32.6	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4	0.0	2.2	0.8	0.7	2.6	1.6	0.5	2.5	0.0	1.2	1.8	3.9	1.4	1.7	0.2	16.5	0.3	1.7	23.3	0.0	15.0	1.3	0.8	0.0	0.9	7.3	4.8	0.0	3.1	1.9	20.0	0.9	1.7	0.0	1.8	3.7	0.6	0.2	0.0	0.7	0.0	4.4	0.0	0.0	7.6	5.9	1.3	1.6	2.5	3.7	1.3
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell type enhanced"	"Detected in single"	28	"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.5	0.0	0.0	30.5	0.0	10.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		630000	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.6	2.6	0.0	0.0	1.0	8.3	0.0	15.5	27.8	0.2	0.6	1.1	13.6	0.0	0.0	32.4	0.0	27.7	0.5	5.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.5	0.0	0.0	0.0	16.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0	145.9	29.7	0.0	10.3	0.7	0.0	0.4	2.5	5.3	36.4	0.0	0.0	0.0	0.0	0.8	5.1	0.0	18.6	23.3	2.9	0.0	2.1	7.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.6	3.3	2.8	66.8	0.0	31.4	31.7	0.0	0.0	0.0	0.0	0.1	2.6	0.2	0.1	0.0	0.0	20.7	121.3
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.9	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	11.3	0.7	40.7	0.0	0.1	0.1	0.0	0.1	1.1	0.0	0.4	0.2	2.0	0.0	0.5	11.9	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.5	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2	0.0	0.0	0.0	0.2	0.1	2.7	10.9	10.2	6.7	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	20.2	0.0	0.0	0.0	0.6	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.3	2.6	0.3	0.0	2.1	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.3
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 3.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.3	13.0	9.1	13.4	4.7	3.3	28.9	7.3	5.2	9.4	9.4	35.3	33.0	9.7	7.7	4.2	26.2	16.8	10.2	8.0	4.1	3.9	17.5	5.3	10.2	19.9	10.4	9.1	9.9	4.9	9.7	8.2	5.4	7.1	7.4	11.3	34.5	9.0	5.2	20.0	6.9	21.9	32.7	15.6	19.5	14.5	1.6	10.4	8.3	15.6	16.5	17.8	6.7	24.9	10.6	11.6	18.9	16.2	7.4	6.9	15.6	16.0	10.0	13.6	8.5	12.5	7.1	15.7	17.5	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7	0.0	1.9	0.0	0.2	0.9	0.8	0.4	0.0	2.7	3.4	0.0	3.9	0.9	0.0	0.6	3.6	0.1	1.6	0.0	0.6	0.6	0.3	0.4	1.1	0.0	0.6	7.9	0.0	0.0	0.3	1.5	0.0	2.5	0.0	0.0	1.9	0.2	0.8	0.0	0.0	0.6	1.1	0.0	0.2	0.5	1.0	0.9	1.4	0.9	1.7	0.8
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.9	9.6	6.3	7.8	12.1	6.9	7.2	3.2	8.8	7.5	9.0	7.9	4.5	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.7	6.6	5.1	8.3	4.5	7.4	6.9	8.6	5.4	4.3	6.8	3.7	7.3	1.2	9.5	6.0	8.5	11.6	6.3	5.7	6.4	10.0	6.2	3.8	2.5	5.3	6.5	7.9	18.2	6.4	5.0	11.7	6.9	11.0	5.8	4.3	10.8	6.7	7.3	6.6	9.2	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3	0.0	10.7	6.0	2.9	2.5	3.9	6.7	7.6	1.4	6.8	5.2	2.0	5.2	3.3	9.4	1.6	7.4	5.1	0.0	5.3	5.6	10.4	4.1	12.8	5.8	6.3	4.8	0.0	3.7	6.3	2.6	13.0	3.9	3.3	10.0	6.4	3.4	5.8	7.0	6.0	4.4	7.2	6.5	8.5	13.1	7.7	1.4	4.7	5.7	6.0	2.7
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 8.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	14.2	10.9	12.1	3.6	13.2	1.2	11.5	5.1	11.1	6.4	7.1	5.6	3.5	2.0	5.4	1.8	5.5	4.8	3.2	6.0	8.3	6.2	7.4	19.5	25.6	6.4	8.6	8.7	3.3	4.0	1.8	4.7	13.3	6.1	6.8	3.7	5.2	4.2	11.8	8.6	2.8	2.6	5.5	4.1	6.5	23.9	2.2	8.6	1.3	16.5	2.3	2.8	6.4	7.2	0.3	8.4	0.0	4.3	0.0	0.0	1.6	0.9	0.4	0.2	10.1	2.5	2.4	1.0	5.8	3.9	1.8	3.3	0.2	0.2	10.6	1.0	7.3	0.1	0.5	0.1	0.0	0.2	2.2	1.8	0.0	1.3	19.4	0.3	0.1	0.7	1.3	0.0	1.1	0.0	1.4	0.5	0.2	0.1	0.1	0.4	0.7	0.0	0.3	1.9	2.0	6.9	0.9	0.0	0.0	0.2	0.0	0.1	4.0	0.0	0.4	2.1	0.8	0.2	0.1	1.4	0.4	2.6	6.1	1.8	0.0	0.0	3.6	3.4	0.2	0.2	0.0	4.3	0.0	0.0	4.2	0.0	0.3	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.6	12.1	13.2	5.1	11.1	8.3	6.2	8.6	8.7	6.1	8.6	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	2.8	0.5	1.4	0.7	0.0	22.2	0.5	0.0	1.2	0.6	13.5	0.6	2.6	1.7	0.0	0.0	2.5	4.3	0.8	8.2	1.1	3.0	0.4	0.0	4.1	0.3	3.1	0.3	0.0	0.0	1.5	0.0
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell type enriched"	"Detected in many"	5	"monocytes: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoli, Nucleoli rim"	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.7	2.7	0.8	2.2	0.7	0.7	4.4	1.5	1.0	1.2	1.7	2.1	1.8	0.6	1.9	1.5	1.6	10.1	2.4	1.0	1.8	13.1	4.0	0.0	7.8	3.2	2.7	0.0	1.1	0.7	2.1	2.1	1.3	1.2	1.0	2.0	0.7	17.3	0.5	3.4	1.9	1.0	0.9	2.3	3.4	0.3	0.7	2.3	0.8	3.2	1.2	3.3	5.8	34.0	2.8	1.7	4.8	0.6	7.1	4.3	1.1	11.1	0.7	16.7	2.7	0.0	3.2	6.7	1.8	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8	6.0	9.9	0.5	6.4	12.0	0.2	12.1	5.1	2.7	6.8	5.2	2.0	25.6	0.0	3.0	0.0	2.9	5.6	0.0	3.3	9.1	3.8	4.4	0.0	12.9	3.8	1.6	0.0	0.0	1.2	0.0	1.7	4.5	6.8	184.0	4.3	1.4	9.2	4.8	4.9	1.4	1.5	0.0	3.9	0.5	2.5	21.2	40.3	2.1	4.3	13.7
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favorable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.9	22.4	10.0	19.3	3.5	4.8	13.8	9.7	5.5	11.2	19.9	16.3	7.8	13.3	31.1	6.5	15.5	11.9	14.2	9.7	8.7	16.0	23.5	9.7	20.9	12.2	3.2	16.0	14.0	7.4	2.5	9.9	6.3	4.9	7.9	12.2	12.2	6.8	6.6	26.9	15.0	19.3	6.2	22.3	22.4	14.1	16.4	20.1	3.5	8.8	11.1	8.4	5.2	11.5	3.9	5.0	4.5	7.7	5.1	9.7	19.2	22.5	17.7	10.1	26.5	52.2	5.1	28.8	13.2	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4	6.0	7.2	4.5	1.3	6.4	1.9	2.0	2.5	5.3	2.3	0.0	3.9	10.4	5.0	7.9	0.0	5.0	5.8	0.0	7.1	20.6	6.2	1.0	19.6	3.9	10.6	3.2	2.4	11.1	11.1	0.0	5.5	8.1	3.3	14.4	11.6	1.9	6.1	10.5	7.1	11.8	1.3	6.5	6.6	1.6	6.3	4.1	7.8	7.4	13.3	1.1
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070438-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments"		NA	NA			"Nucleoli, Nucleoli rim"	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	17.9	12.9	11.2	14.3	14.3	17.7	12.6	24.3	17.7	14.4	14.0	11.6	12.9	7.9	17.0	13.0	9.1	11.1	11.5	11.1	12.0	9.7	11.8	17.3	14.8	14.6	10.7	6.2	20.5	13.9	34.1	33.5	19.2	16.5	11.9	10.9	12.2	12.4	10.9	18.9	9.0	15.6	12.2	13.5	17.3	11.7	16.4	12.7	34.1	15.3	8.8	13.9	15.3	11.9	4.8	4.4	4.3	4.9	4.0	11.0	3.2	7.6	7.6	9.3	9.6	11.8	6.6	14.3	6.8	6.7	8.9	9.7	11.1	6.0	15.7	5.6	9.0	5.7	8.0	17.8	8.6	14.3	6.0	5.5	20.1	8.4	9.1	5.7	16.6	12.3	7.8	8.2	8.8	11.1	6.9	13.7	11.7	13.9	10.0	7.4	9.7	21.3	5.7	5.7	6.9	7.3	14.4	16.9	6.9	7.2	10.8	9.4	8.6	10.7	8.9	11.7	13.5	10.6	10.3	12.3	11.5	13.2	6.2	6.0	8.3	9.6	11.9	5.7	10.3	11.9	3.6	4.9	4.3	8.8	4.5	11.0	2.9	5.4	5.3	4.4	4.8	3.3	4.5	3.7	4.0	2.9	3.6	4.8	3.2	11.2	14.3	24.3	17.7	12.0	9.7	10.7	6.2	16.5	12.7	17.9	29.6	17.6	21.6	28.5	49.3	24.4	22.9	21.4	29.6	26.2	88.4	26.8	6.6	15.0	3.7	24.5	22.3	0.0	12.2	34.0	24.9	25.4	33.4	40.0	27.1	63.5	36.8	63.8	75.2	7.2	35.9	25.6	13.5	10.8	29.0	24.5	16.1	21.0	40.3	12.1	51.1	12.9	22.6	36.7	24.8	17.7	15.3	76.1	22.6	32.3
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.1	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.7	5.3	2.9	10.1	32.6	20.0	18.0	13.3	24.4	12.5	6.8	20.6	18.6	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	5.2	11.4	16.5	17.4	13.3	33.6	17.2	23.7	18.7	19.3	13.4	16.0	18.4	33.9	9.5	9.4	10.3	13.0	8.1	14.8	11.2	10.5	10.8	8.4	13.1	8.3	19.8	21.6	14.5	27.7	12.7	10.0	21.4	11.9	12.5	49.3	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.8	0.4	1.1	0.0	0.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	0.0	12.4	0.1	0.9	46.7	0.0	13.7	0.3	0.4	0.0	0.0	5.7	0.0	0.0	2.5	2.4	7.4	0.6	2.1	0.0	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	18.4	12.9	0.6	1.3	1.3	1.2	0.6
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Cell type enhanced"	"Detected in many"	17	"Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HMC-1: 19.7;THP-1: 10.0;U-937: 10.5"									"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.7	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	1.1	1.0	0.0	0.5	0.2	0.2	0.5	1.0	2.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9	0.0	1.7	0.5	0.4	0.6	0.0	0.9	0.0	1.4	2.3	1.8	0.0	1.4	6.6	0.9	0.7	1.4	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.8	2.2	3.2	0.0	2.5	14.6	0.0	0.3	9.5	0.0	0.0	0.3	0.3	0.0	0.0	0.4	1.2	0.1	0.0	0.4	0.2	0.1	0.5	2.3	30.5	0.2	1.2
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 35.9;HaCaT: 37.3;hTCEpi: 33.7;RPTEC TERT1: 32.8"									"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"		NA	NA			Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	3.9	11.8	15.9	2.1	37.3	0.7	22.2	13.7	29.0	12.6	5.0	6.9	6.2	3.2	10.0	15.8	32.8	33.8	5.8	12.9	16.7	6.7	20.1	2.6	4.0	2.0	6.6	18.4	11.1	5.2	7.4	6.1	17.2	6.8	15.3	7.3	8.4	12.5	16.4	2.8	39.3	2.2	8.7	6.0	2.9	7.0	4.1	10.7	5.7	13.6	20.1	11.7	8.5	18.3	0.3	0.7	0.7	0.3	0.0	1.8	0.2	5.5	19.1	35.9	3.8	21.1	3.4	4.6	4.6	7.0	7.4	7.4	1.8	6.4	1.1	17.9	9.8	6.1	37.3	6.8	10.1	7.0	1.0	3.3	1.2	4.2	3.0	4.0	0.6	1.8	5.7	33.7	2.1	14.0	9.5	7.0	8.2	0.4	0.5	5.2	7.9	5.5	1.7	3.6	18.4	8.8	2.9	2.1	0.8	32.8	8.2	3.7	14.2	6.8	9.2	3.1	21.6	8.4	1.5	3.8	8.3	2.6	1.6	5.1	1.7	1.4	0.1	3.1	3.7	12.3	0.0	0.1	0.7	0.8	0.1	1.6	0.0	1.8	0.6	0.7	0.3	0.7	0.5	0.0	0.0	0.3	0.3	0.0	0.2	15.9	37.3	13.7	29.0	16.7	6.7	6.6	18.4	6.8	10.7	3.0	2.6	0.0	39.9	28.2	3.9	10.1	5.1	29.4	14.8	24.4	7.9	41.6	99.5	7.7	26.4	2.4	1.3	0.0	3.2	5.2	2.6	13.8	0.0	1.8	3.9	20.6	1.2	2.5	1.0	6.7	4.9	1.0	21.9	0.0	4.3	19.5	8.6	0.0	2.8	6.8	6.3	0.0	3.1	1.9	3.7	38.9	27.8	0.0	4.7	35.3
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Cell type enhanced"	"Detected in many"	7	"Urothelial cells: 190.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 44.6"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.7	4.8	8.4	3.2	3.8	4.6	12.6	3.3	3.3	2.4	2.6	18.3	18.0	13.1	8.3	2.7	8.1	3.6	11.5	2.2	3.4	9.6	1.6	18.3	2.4	2.4	7.5	13.2	29.7	2.5	3.4	2.6	4.4	9.6	18.5	9.0	10.4	20.9	2.5	1.3	18.5	5.5	18.0	10.4	2.0	8.6	8.0	5.7	2.3	5.1	3.4	3.0	4.3	2.2	2.3	44.6	7.7	14.6	11.7	2.5	4.0	4.3	3.5	12.7	13.4	16.1	1.3	7.4	2.7	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9	32.8	30.1	76.8	35.9	16.7	12.1	16.6	12.7	10.7	22.7	7.0	9.8	10.5	0.0	11.8	4.8	41.3	43.3	0.0	10.4	2.2	15.8	43.7	43.9	40.9	27.9	17.5	8.6	25.8	50.9	5.2	23.9	40.7	10.1	26.2	12.5	8.5	24.6	14.0	22.3	6.7	15.8	77.6	22.7	5.2	36.4	30.5	4.2	83.0	13.0	190.4
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822901-53825213	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	261	"testis: 103.6"	"Group enriched"	"Detected in some"	82	"Early spermatids: 638.1;Late spermatids: 419.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	638.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.5	0.0	4.2	2.0	0.0	0.0	0.0	0.0	0.0
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal glandular cells: 1442.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	69.8	10.0	8.4	26.3	10.6	80.6	101.1	7.4	10.1	28.6	31.7	10.3	9.7	11.0	24.9	28.8	38.6	28.0	38.6	18.6	7.8	5.1	32.2	32.5	46.0	35.8	13.8	4.2	20.2	23.8	7.5	4.7	26.1	11.2	20.1	21.0	13.2	26.9	16.5	57.8	60.2	44.8	42.8	17.0	20.3	26.7	14.3	10.0	12.5	41.0	28.8	21.5	44.7	30.7	15.6	29.8	77.8	18.7	13.0	30.8	23.2	13.2	3.6	6.9	2.2	40.3	40.4	4.3	22.8	11.7	24.4	16.6	9.3	17.9	3.8	5.3	24.7	19.0	8.1	4.2	21.1	20.5	18.6	2.5	0.5	4.1	8.7	17.3	2.5	13.1	13.3	40.3	17.4	33.2	8.7	24.9	2.5	4.1	29.7	31.0	0.9	4.6	3.8	2.6	7.1	6.5	3.0	7.1	13.4	24.0	13.2	3.0	2.9	5.6	16.3	34.2	19.6	8.0	2.1	32.4	33.1	4.6	19.5	10.4	5.7	18.5	7.0	8.9	3.3	10.2	50.9	17.0	43.7	27.1	14.2	23.9	15.6	30.8	26.8	13.1	12.5	9.6	14.8	77.8	13.0	18.7	29.8	22.2	23.2	8.4	10.6	7.4	10.1	7.8	5.1	13.8	4.2	11.2	10.0	1158.3	540.6	237.0	1442.7	520.2	42.2	53.1	293.0	254.3	251.4	130.9	31.4	113.5	18.3	616.6	54.4	455.0	961.8	70.0	474.3	369.8	410.0	832.0	597.5	234.2	510.8	35.0	381.0	212.4	420.1	42.4	120.8	593.9	458.9	839.6	556.8	32.1	706.5	466.4	125.9	61.9	78.0	135.8	372.0	6.2	13.6	549.2	163.8	409.2	300.8	382.6
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032058, HPA043197"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA032058: AB_10601439, HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	1.0	3.7	4.0	1.0	8.4	0.9	1.4	3.1	9.5	1.8	2.4	2.3	5.6	1.6	2.4	3.9	1.1	5.7	2.4	1.7	3.3	4.9	5.9	2.6	1.7	1.0	3.6	7.4	2.5	3.6	4.1	4.8	1.0	5.6	3.2	1.6	3.5	2.9	2.4	2.5	0.8	1.6	1.1	1.6	1.1	2.4	24.3	2.2	0.0	5.0	0.0	1.1	1.5	0.6	0.9	0.1	0.0	0.2	0.0	1.1	0.1	0.4	2.7	1.0	2.9	0.0	0.3	0.3	0.0	0.7	0.1	0.0	0.0	0.2	0.0	5.0	0.0	0.0	1.6	0.0	0.0	0.0	3.5	3.7	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.5	0.0	1.5	0.5	2.4	2.6	0.0	1.9	0.6	0.0	2.5	1.1	0.0	1.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	4.0	8.4	3.1	9.5	3.3	4.9	3.6	7.4	5.6	2.2	0.0	4.1	0.0	11.1	0.8	13.0	8.5	7.6	53.5	9.1	27.9	2.0	2.3	48.0	6.8	336.6	3.3	3.2	0.0	4.9	2.8	3.5	10.5	1.1	7.3	0.5	3.2	5.2	1.8	0.3	352.6	7.5	0.3	6.8	1.0	12.5	27.9	4.2	7.0	7.8	29.8	16.9	12.9	1.9	259.8	11.1	0.6	0.7	0.0	7.6	5.6
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.4	21.1	13.3	11.8	10.5	9.6	24.3	22.3	14.2	17.6	11.3	15.4	13.4	27.1	18.2	11.0	17.6	13.4	17.8	19.6	19.9	22.3	18.1	26.2	11.7	17.9	12.7	46.1	16.6	9.9	16.8	20.2	19.3	17.8	12.0	25.9	28.9	8.7	17.2	16.8	26.8	13.1	19.6	14.1	19.3	21.3	25.6	16.3	19.6	32.2	16.0	13.3	21.1	15.0	26.3	13.3	24.9	18.8	14.9	16.3	10.8	16.8	23.1	17.4	21.8	17.0	8.8	16.3	29.3	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3	65.5	42.2	31.8	91.0	43.6	53.3	22.4	15.3	48.2	54.6	38.4	31.4	56.6	49.7	37.5	4.0	32.2	15.1	0.0	42.7	45.8	41.4	40.8	36.9	36.7	26.1	69.9	17.2	22.1	18.8	5.3	48.6	29.3	11.8	32.5	23.2	65.0	33.7	27.9	50.2	37.3	53.6	12.9	36.3	55.6	54.8	38.8	58.9	48.4	29.3	62.9
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	76	"brain: 11.8;skeletal muscle: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.8;pons and medulla: 3.2"	"Group enriched"	"Detected in some"	21	"cerebellum: 2.9;pons and medulla: 2.8"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.4	0.0	0.0	0.0	13.6	0.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 733.2;Spermatocytes: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.4	10.3	5.6	15.7	4.3	3.2	8.7	7.9	5.2	13.6	9.4	9.9	4.3	18.4	11.4	6.0	16.0	7.9	8.2	7.1	4.0	6.4	15.9	3.8	4.7	6.1	5.7	7.1	7.4	3.0	4.3	15.7	3.3	4.6	7.1	14.4	17.8	5.7	7.3	22.4	21.3	16.9	11.9	9.4	15.0	11.3	5.2	19.8	4.0	4.7	7.4	21.1	8.7	8.4	7.7	6.8	4.8	5.9	4.1	7.5	16.1	23.2	12.6	20.9	36.0	17.6	8.3	6.6	13.0	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8	0.0	0.6	5.2	5.8	9.3	11.7	0.7	2.5	16.0	6.8	12.2	2.0	7.7	6.6	12.2	733.2	5.8	7.9	0.0	9.2	9.8	5.7	3.5	0.0	6.8	7.8	4.8	7.5	5.5	5.7	71.5	17.5	3.9	5.0	10.0	6.3	8.6	9.9	6.0	14.9	11.5	8.1	0.0	5.1	397.6	39.9	8.5	5.1	7.0	6.3	3.3
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	16.2	34.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	3.9	1.4	3.3	0.0	0.0	0.0	0.0	0.3	0.2	9.3	0.7	8.4	0.8	2.0	3.1	0.8	0.1	0.2	9.2	0.1	13.4	0.0	0.0	0.0	0.0	8.9	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8	20.8	32.3	6.7	25.3	60.9	14.6	153.6	7.6	0.0	13.6	48.8	23.6	7.5	1.7	2.0	0.6	19.9	50.9	0.0	3.0	2.1	61.9	37.1	10.4	32.6	322.7	3.2	55.5	34.4	488.8	0.7	27.3	252.1	20.3	0.0	13.7	25.8	5.4	24.6	23.0	0.8	8.2	12.9	44.3	0.5	0.9	77.0	10.4	4.4	8.1	17.7
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 78.9;Late spermatids: 220.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	13.0	20.5	6.2	8.1	5.2	7.8	15.7	8.6	4.4	5.5	6.2	27.9	7.5	7.7	15.9	5.5	6.4	7.2	5.0	7.0	2.3	9.6	28.7	6.9	18.2	18.2	11.1	7.6	10.0	8.5	4.0	8.3	5.2	3.9	10.9	5.9	10.7	4.4	2.9	18.3	9.3	19.3	13.6	8.2	24.0	15.1	4.8	7.8	7.1	20.0	11.0	12.1	4.8	7.4	8.6	4.7	4.7	8.4	16.8	10.1	8.7	19.5	12.9	8.3	10.0	7.8	11.6	12.2	11.8	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1	3.0	6.9	9.5	12.3	9.2	10.0	4.8	10.2	0.0	4.5	3.5	7.9	17.5	3.3	18.4	78.9	12.8	21.7	0.0	14.9	13.7	10.1	12.1	10.3	3.9	23.4	38.1	19.5	25.8	19.1	220.0	20.8	18.7	1.7	16.2	12.9	7.8	17.9	14.0	29.7	5.2	5.9	12.9	11.4	16.3	26.4	2.9	28.3	10.9	13.1	12.3
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 143.1;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.6	0.1	0.3	0.2	1.2	5.7	2.7	1.6	0.2	0.2	0.5	16.3	19.4	4.7	1.2	1.5	2.8	15.2	0.0	46.2	0.4	12.0	5.2	0.1	0.5	16.2	2.0	0.1	1.2	4.9	16.4	3.0	0.6	2.3	3.0	0.5	0.3	5.3	0.5	10.3	0.1	1.2	0.1	19.4	0.3	11.6	0.2	27.9	9.0	28.9	19.6	0.3	1.7	0.3	0.1	0.6	22.0	2.5	4.1	1.4	0.2	0.5	0.3	0.3	7.0	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1	26.8	24.1	11.5	34.8	24.3	0.8	1.6	22.9	1.4	22.7	27.9	5.9	41.4	13.3	48.4	89.5	2.3	143.1	0.0	102.6	8.3	3.2	28.0	2.3	1.6	35.8	0.0	63.0	0.6	6.1	214.3	6.6	6.4	16.9	22.6	80.8	1.5	76.0	89.2	9.2	7.9	2.2	0.0	1.0	6.1	1.5	46.5	27.0	20.2	93.7	47.8
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.1;NTERA-2: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.6	4.6	4.8	4.5	7.9	7.5	4.8	3.2	2.4	3.6	4.5	10.6	1.7	14.0	3.7	3.3	3.9	4.1	12.4	4.3	6.5	5.5	8.2	15.2	5.9	6.9	3.0	19.6	3.8	4.6	3.7	9.7	9.0	2.2	6.4	6.4	27.1	3.4	3.5	5.6	3.0	7.4	26.4	3.9	4.0	6.1	9.1	3.5	3.2	6.6	8.7	3.9	4.5	2.7	2.9	6.6	1.9	8.7	8.2	2.4	4.5	3.2	7.4	3.9	4.3	6.9	3.3	11.2	4.2	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7	26.8	15.5	8.5	5.2	26.1	24.4	30.7	7.6	13.4	25.0	14.0	23.6	4.9	0.0	5.9	6.0	13.3	4.6	23.3	6.9	5.7	10.0	7.3	5.8	41.4	5.9	17.5	7.5	9.2	3.3	2.5	6.6	6.6	11.8	2.8	6.9	7.8	5.6	3.5	8.1	1.8	19.5	0.0	9.5	21.7	50.0	26.3	2.9	9.6	9.3	8.7
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"	"Group enriched"	"Detected in some"	15	"NB-4: 36.7;THP-1: 69.4;U-937: 45.4"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		110000	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3	32.8	82.3	20.5	0.0	2.2	0.6	0.7	10.2	14.7	17.0	0.0	0.0	0.8	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.9	2.3	0.0	40.7	1.3	203.8	0.0	0.0	6.2	493.3	0.9	1.1	520.9	1.7	25.2	0.0	130.5	0.0	0.0	0.0	1.1	4.7	12.9	9.2	0.3	0.2	1.9	0.8	1.0	0.0	0.0
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	6	"Enterocytes: 108.9;Paneth cells: 59.6"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	1.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	108.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	59.6	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.2	0.0
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 32.0;SK-MEL-30: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	16.9	19.4	37.2	7.5	34.9	32.7	26.5	56.4	36.9	20.3	26.4	33.9	20.1	12.0	26.0	23.8	39.5	19.1	17.4	36.0	35.1	26.6	23.9	30.5	16.5	7.1	37.0	25.9	46.4	23.1	25.6	12.1	14.4	26.2	24.5	22.1	15.8	41.2	32.7	22.8	25.4	22.5	18.2	44.7	7.8	14.7	13.5	38.1	7.0	29.2	13.4	9.8	32.8	33.9	4.5	2.2	11.0	4.7	1.4	8.6	2.3	5.4	2.2	5.6	11.2	8.8	6.7	2.4	3.2	10.8	2.1	6.6	0.9	9.8	7.2	5.2	5.5	3.5	7.1	6.7	7.6	5.6	3.6	9.0	1.9	4.4	4.1	5.8	3.8	4.3	7.1	29.0	3.7	14.8	32.0	2.0	5.7	7.1	15.6	3.5	3.5	2.5	7.8	2.4	8.9	6.7	1.6	7.3	11.4	7.3	0.5	9.5	15.7	3.1	2.3	52.2	7.3	2.6	12.5	2.0	3.7	6.4	4.0	1.6	12.9	6.8	2.6	10.0	14.2	3.9	2.2	3.1	11.0	3.1	2.5	5.8	3.9	6.7	3.6	1.7	4.5	8.6	2.2	7.8	1.4	4.7	2.2	5.0	2.3	37.2	34.9	56.4	36.9	35.1	26.6	37.0	25.9	26.2	38.1	14.9	15.6	8.3	48.3	51.5	37.3	78.1	28.1	21.4	31.8	31.4	45.2	3.4	39.7	15.1	4.1	38.3	50.6	116.8	12.7	13.2	31.9	46.8	3.5	46.4	10.1	49.3	16.3	19.6	18.4	7.0	41.7	19.0	99.5	18.0	20.8	127.5	14.4	35.1	52.3	53.0	43.0	45.3	88.6	8.6	26.0	58.8	8.1	21.3	15.6	33.1
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 130.3;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 84.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 16.5;SH-SY5Y: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.3	3.0	0.4	0.0	0.1	3.4	5.2	4.0	3.3	0.0	0.5	1.4	0.0	5.8	2.2	0.1	1.8	0.7	8.4	0.6	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	16.5	0.7	0.6	0.0	9.7	0.5	1.0	0.5	0.0	2.3	2.9	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.0	2.5	0.0	1.7	4.3	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.5	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0	26.8	8.6	0.5	5.0	0.9	130.3	43.7	12.7	61.6	14.8	8.7	137.4	0.1	1.7	7.3	14.9	6.3	0.0	0.0	1.5	0.1	8.3	8.7	23.3	0.0	0.7	44.5	22.0	9.2	2.4	11.0	16.4	2.9	6.8	1.0	1.4	66.5	2.3	0.0	18.0	7.1	84.5	6.5	12.2	4.9	5.9	0.6	0.0	0.0	0.8	13.1
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	6	"AF22: 32.3"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	32.3	0.0	0.0	0.3	0.1	0.5	5.7	0.5	0.6	0.0	0.0	2.4	0.0	0.3	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.3	2.7	3.1	0.4	5.3	0.5	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.7	0.2	1.0	0.3	0.0	1.3	0.7	0.7	0.1	1.0	0.0	1.2	1.6	0.3	0.5	0.0	1.6	0.2	0.2	4.7	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6	244.2	14.1	0.0	0.4	7.9	119.6	16.1	0.0	1.4	51.2	1.8	39.3	0.0	3.3	0.4	5.4	0.8	11.0	0.0	0.2	0.1	5.2	0.9	1.1	5.3	0.5	31.8	3.5	0.6	5.1	2.7	24.5	6.8	1.7	6.4	3.3	83.1	0.9	4.9	7.1	9.0	5.6	6.5	8.1	0.1	0.7	2.5	0.0	0.0	0.9	1.6
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes		600000	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	63.3	59.3	71.9	52.7	42.5	46.2	74.0	71.7	48.7	67.7	60.0	97.9	45.6	84.2	61.8	55.3	90.9	62.2	143.9	96.3	116.1	49.2	60.3	140.5	56.3	131.9	46.6	160.1	53.3	43.8	55.9	84.5	89.0	38.9	71.0	76.8	125.1	28.9	59.5	86.2	140.1	99.4	107.1	66.9	42.6	104.6	129.7	73.9	49.7	84.2	62.3	44.4	48.0	55.1	63.3	61.3	41.4	81.1	60.3	54.3	56.2	63.4	94.2	54.8	53.8	181.3	39.5	104.5	56.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4	271.0	357.6	280.1	370.4	408.5	137.1	290.7	137.6	385.4	589.2	184.9	45.2	333.3	195.6	173.5	15.4	228.8	106.1	210.2	218.7	336.0	249.6	218.4	431.8	217.9	213.5	76.3	191.8	122.8	135.8	18.9	201.0	194.7	156.9	238.1	192.5	194.0	213.8	138.2	150.3	209.2	125.5	148.8	282.2	390.1	563.8	385.9	316.9	226.1	268.8	321.5
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			Centrosome	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.3	8.7	18.3	15.5	7.0	11.4	7.6	10.6	9.1	8.9	7.5	5.6	6.6	29.1	7.3	14.3	8.5	13.0	14.7	6.7	18.9	14.0	4.5	10.7	5.4	5.3	4.1	18.6	30.9	7.8	5.4	15.7	6.4	5.3	14.2	15.1	2.6	11.9	13.5	13.5	14.1	7.5	2.5	3.9	9.7	16.0	33.8	2.1	8.0	14.0	8.5	9.6	13.3	4.0	11.4	4.2	7.6	16.6	20.7	22.8	31.7	8.7	11.7	9.6	4.8	20.1	5.9	15.2	12.3	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0	6.0	7.7	41.0	7.0	16.4	7.5	37.9	12.7	26.8	36.4	10.4	58.9	9.2	3.3	6.9	22.3	24.1	4.1	0.0	3.5	8.9	27.9	13.0	30.1	3.9	20.1	6.4	12.1	27.0	40.6	7.8	7.8	47.2	21.9	12.6	3.9	87.7	4.7	5.8	8.9	5.1	18.0	32.3	20.8	0.0	0.4	18.3	8.1	37.4	4.6	14.5
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693478	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.1"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003547	Uncertain		Approved	"Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles"		Yes	No			"Nucleoli, Mitotic chromosome"	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favorable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (3.24e-4)"	3.8	11.8	9.3	9.5	10.1	14.6	5.0	13.1	10.6	3.6	6.5	7.9	5.4	8.4	4.1	4.6	7.8	6.2	5.6	7.2	7.7		5.2	4.1	4.8	11.0	8.7	6.4	5.4	5.4	5.4	3.9	6.8	7.2	4.5	6.2	4.4	8.9	4.8	7.9	11.4	7.1	4.5	3.7	8.6	5.8	4.8	9.5	7.2	7.4	7.1	8.0	5.8	5.6	8.1	9.6	31.1	17.1	8.5	11.6	6.4	16.9	15.7	11.7	13.4	3.8	4.0	14.8	8.5	3.9	3.8	4.1	8.8	7.1	14.5	5.1	3.8	4.0	18.5	6.7	22.4	1.3	15.2	24.5	12.3	12.6	20.1	10.3	29.1	18.1	5.9	7.3	15.2	5.9	5.3	7.3	8.6	9.1	13.1	3.3	14.8	15.9	21.7	13.4	7.6	21.2	21.8	7.6	10.9	8.5	6.0	9.5	18.7	9.9	9.1	13.5	1.8	13.0	13.8	10.2	16.2	16.4	11.8	15.6	11.0	13.4	18.7	15.4	21.6	18.9	21.3	14.0	14.2	9.1	14.1	6.5	8.0	8.9	7.9	9.6	8.1	9.1	7.9	31.1	8.5	17.1	7.5	11.6	6.4											3.0	11.7	16.1	10.3	34.7	11.5	3.1	7.6	9.4	7.9	14.0	5.9	16.5	3.3	23.3	77.4	12.6	26.9	0.0	25.4	13.3	12.5	7.3	15.0	4.9	12.1	27.0	12.1	9.8	8.7	31.6	9.2	16.0	20.3	19.0	18.9	9.1	18.7	31.6	10.6	6.4	8.1	12.9	8.2	14.4	24.4	34.8	16.6	16.7	18.4	13.2
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.8	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.3	0.8	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.2	0.1	0.3	5.8	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.5	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5	0.0	0.0	0.0	0.1	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	24.4	28.1	26.0	26.1	30.1	28.2	29.6	19.0	31.8	19.7	21.9	27.2	18.1	20.4	28.0	21.3	31.2	28.0	22.7	18.1	26.3	18.5	24.2	34.9	19.8	30.0	27.2	26.6	30.5	49.0	31.3	17.0	20.2	23.6	24.2	19.2	18.6	22.2	22.1	34.1	32.3	19.8	22.9	24.3	26.4	25.2	34.5	27.2	21.2	25.3	23.1	24.9	21.8	22.6	14.4	17.8	3.9	19.4	12.4	16.2	16.3	34.3	39.2	14.5	30.8	16.7	16.4	22.3	22.9	18.8	39.1	30.5	45.4	14.8	46.6	20.5	26.0	30.2	24.0	44.5	40.8	28.8	19.9	42.8	22.6	22.5	39.1	41.7	54.5	23.8	23.1	25.7	40.6	40.9	18.7	25.1	16.7	37.2	19.0	23.6	43.3	26.4	55.3	28.1	33.8	28.8	33.8	25.3	45.6	21.4	23.8	25.1	26.0	22.6	25.8	30.3	12.1	18.1	28.0	19.8	45.9	34.8	23.3	38.2	24.2	20.7	47.6	32.2	25.1	29.3	3.9	15.8	3.9	13.3	19.4	16.2	14.4	12.4	12.7	17.8	13.8	14.2	12.7	0.6	12.4	13.9	15.4	9.5	16.3	26.0	30.1	19.0	31.8	26.3	18.5	27.2	26.6	23.6	27.2	3.0	17.6	13.7	18.1	20.0	6.4	3.4	25.5	26.8	19.4	24.4	7.9	30.6	21.6	36.3	38.4	21.1	24.6	0.0	38.0	33.3	14.9	13.1	17.4	20.7	33.9	3.2	22.5	28.8	29.7	10.4	18.4	20.8	20.3	31.5	19.9	13.1	33.1	14.0	19.1	39.6	8.1	19.4	18.4	23.5	19.3	19.9	23.8	15.0	24.7	12.2
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.0;HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	23.0	10.0	4.3	3.6	3.9	5.3	29.3	5.4	5.2	5.5	5.9	10.7	8.8	9.3	14.8	5.3	10.6	9.9	5.6	8.6	9.9	11.8	6.3	42.0	6.8	6.4	4.0	10.2	66.6	4.5	6.6	3.8	7.8	9.8	8.3	4.5	16.0	6.9	6.9	10.6	5.9	7.2	6.2	17.0	9.4	4.3	4.5	6.6	8.5	12.8	3.7	2.7	15.0	6.5	19.3	13.2	16.3	24.4	8.7	3.5	4.5	7.7	7.6	11.7	7.6	8.5	8.6	9.9	4.9	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7	8.9	14.7	4.7	12.9	16.9	15.4	30.2	12.7	14.7	21.6	17.4	23.6	29.1	5.0	9.4	0.9	8.5	21.3	0.0	16.5	46.3	6.5	23.0	13.9	15.8	13.4	20.6	15.6	11.6	28.8	1.1	3.4	19.7	6.8	14.4	14.9	8.2	15.2	21.8	6.3	18.9	17.9	6.5	6.1	10.7	14.9	20.5	40.0	6.1	12.7	15.3
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.5	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.6	0.0	0.0	0.1	7.2	0.3	2.7	0.0	0.1	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.2	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.2	0.3	0.1	0.6	0.0	0.0	0.1	0.0	1.9	0.5	0.1	0.1	5.3	0.0	0.9	9.7	0.4	0.8	0.0	0.2	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	5.1	0.0	9.0	18.5	0.0	0.8	0.0	1.4	2.3	10.4	0.0	1.2	0.0	3.6	1.7	0.0	0.3	0.0	1.2	0.2	0.2	5.0	0.0	0.4	0.1	0.0	2.9	0.0	0.0	3.8	0.0	0.0	5.0	0.0	0.0	0.2	12.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	33.0	6.6	0.0	0.5	10.1
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.5	14.5	14.6	20.0	21.7	16.3	22.1	15.4	8.4	14.2	10.8	18.8	10.7	16.5	6.9	14.3	22.3	12.0	44.2	17.7	17.3	54.5	15.4	29.5	13.1	25.8	16.8	18.4	22.2	10.3	14.4	12.1	18.2	18.4	15.4	28.2	36.7	29.4	15.8	14.9	26.4	16.7	20.1	25.5	19.4	12.0	7.2	14.1	15.6	7.8	24.7	16.6	11.5	24.0	21.9	22.1	11.0	17.7	14.9	14.2	16.0	15.6	20.3	16.9	35.0	21.0	18.1	20.0	14.2	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4	6.0	12.0	18.8	25.3	9.0	24.6	50.0	28.1	76.3	33.0	26.2	21.6	33.4	31.5	34.8	23.6	25.6	19.0	0.0	20.1	39.2	21.3	25.8	31.2	16.1	36.7	71.5	18.8	18.4	11.0	15.7	19.0	21.8	13.5	63.1	22.9	21.7	26.7	21.6	21.2	24.9	25.3	6.5	30.2	78.8	76.3	10.3	39.8	27.4	24.2	17.2
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 25.8"	"Group enriched"	"Detected in some"	8	"Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.5	1.0	2.2	1.3	5.8	3.5	0.8	2.6	2.9	1.0	0.5	0.7	0.6	0.7	0.8	0.8	1.0	0.9	1.1	0.3	1.8	1.6	0.7	0.9	0.6	0.9	0.9	0.8	0.9	0.5	1.0	0.8	1.2	1.7	0.9	0.5	0.6	1.0	0.8	0.6	1.3	0.8	0.7	1.6	0.7	0.6	25.8	1.0	1.3	0.8	0.3	0.9	0.8	0.5	3.1	2.3	2.8	2.2	2.6	2.9	1.3	3.9	6.1	3.3	4.5	0.2	0.3	3.5	2.3	1.8	5.4	5.1	2.5	3.8	0.7	7.0	1.9	4.0	1.3	1.6	1.7	1.2	2.6	1.5	4.2	3.6	1.5	1.2	1.1	2.6	1.8	2.4	3.5	0.7	1.1	0.9	4.4	2.2	2.0	2.4	9.3	3.9	2.0	3.5	3.7	0.0	1.6	0.6	0.4	1.8	3.4	7.6	3.0	3.2	2.3	0.9	1.1	3.0	1.5	1.2	3.6	5.3	0.9	3.1	0.4	1.4	1.2	3.8	2.9	3.6	2.8	2.2	0.6	2.4	1.8	0.8	3.1	1.7	2.3	2.3	2.2	2.3	1.3	2.4	2.6	0.7	1.5	2.9	1.3	2.2	5.8	2.6	2.9	1.8	1.6	0.9	0.8	1.7	1.0	0.0	0.3	0.0	0.7	0.6	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.7	1.7	0.9	22.2	0.5	0.4	0.0	1.0	0.6	0.4	0.4	0.0	0.2	0.7	1.6	0.0	0.0	0.0	45.8	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.1	0.5	0.1	0.0	0.6	32.9	25.6	0.6	0.5	0.0	0.5	0.4
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.5	14.1	20.6	11.4	12.5	16.3	33.8	13.0	15.7	12.3	10.4	20.5	21.0	22.1	19.8	12.5	5.7	13.9	15.8	27.8	9.9	17.0	11.8	18.0	12.0	25.2	15.3	20.8	16.5	14.7	17.9	13.8	20.8	15.6	13.0	9.9	15.3	24.6	14.4	26.5	13.3	37.2	35.9	20.1	7.3	12.0	8.2	25.3	25.2	25.0	13.9	16.0	16.6	22.3	11.6	20.0	27.1	44.1	10.1	7.4	10.5	11.5	9.4	13.0	19.7	34.1	12.7	14.5	11.6	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1	17.9	15.9	15.9	26.4	0.0	13.6	0.0	28.1	30.8	26.1	22.7	7.9	72.4	66.3	34.7	9.6	12.4	38.3	23.3	44.0	61.6	11.5	34.5	17.4	32.7	48.8	6.4	7.0	19.0	44.8	7.4	21.6	40.2	0.0	146.1	41.7	34.7	43.4	37.0	22.3	44.1	10.6	12.9	0.0	18.1	24.3	0.0	51.8	37.4	37.7	28.0
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309192-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 26.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 63.9;SK-BR-3: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	27.6	13.5	5.0	18.6	7.6	32.3	23.7	11.5	15.2	30.2	29.6	5.0	16.8	18.0	23.8	23.9	17.3	23.3	30.2	24.3	5.9	6.1	14.6	24.0	32.0	23.4	4.6	7.8	50.0	9.3	7.4	18.1	16.6	6.5	22.9	8.5	26.8	12.1	32.7	43.1	14.3	31.6	18.6	3.7	31.1	14.3	21.8	2.9	9.7	16.3	15.4	20.2	31.5	20.3	1.0	6.1	26.6	9.3	2.5	2.6	1.9	5.1	12.1	3.6	6.1	7.1	10.9	3.6	4.2	6.4	6.2	4.0	8.3	4.4	2.7	6.6	9.5	5.7	15.0	4.1	10.0	3.6	20.5	6.1	7.8	6.1	8.1	11.4	2.8	24.7	15.3	2.9	6.6	8.4	23.7	9.2	2.4	4.9	6.0	7.0	63.9	1.8	9.5	3.1	4.7	3.8	3.6	21.3	10.3	3.6	4.1	1.5	12.4	9.0	40.6	12.4	3.6	38.2	11.2	10.7	7.8	13.3	13.6	4.6	14.4	4.8	2.3	13.1	5.5	23.0	8.7	4.2	15.7	1.6	6.9	2.6	1.0	1.7	1.7	6.1	0.9	0.8	1.3	26.6	2.5	9.3	1.8	1.4	1.9	5.0	7.6	11.5	15.2	5.9	6.1	4.6	7.8	6.5	2.9	3.0	9.5	5.6	22.6	17.3	24.2	3.2	10.2	4.0	2.3	7.0	5.9	1.9	11.6	14.3	58.0	20.4	52.7	0.0	16.9	5.1	23.8	11.2	34.6	22.8	11.3	3.2	9.2	22.7	35.4	50.8	38.6	37.4	27.0	0.0	14.2	9.3	16.8	24.6	21.5	11.8	8.2	32.3	33.0	2.9	6.9	16.6	4.3	11.5	13.2	19.2
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 28.5;monocytes: 28.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	23.4	5.9	16.7	17.0	25.5	6.0	8.4	12.5	36.5	3.6	8.2	26.7	12.1	11.2	2.6	14.9	4.3	3.3	9.0	29.1	16.6	15.1	37.2	10.5	9.7	14.1	34.5	9.7	3.0	11.5	2.2	8.4	10.4	19.4	4.5	5.3	8.4	14.0	9.9	7.6	2.9	10.8	7.0	21.8	12.6	4.3	5.7	31.5	1.2	23.0	2.9	7.4	8.3	3.9	0.0	28.5	0.9	28.3	2.2	3.0	13.8	0.4	0.1	2.0	3.9	6.1	0.3	1.4	0.2	0.3	0.6	1.2	1.6	0.2	0.0	0.7	0.2	1.3	0.0	0.8	0.9	0.9	12.2	0.0	0.0	0.0	12.7	6.5	0.8	0.0	4.5	0.0	0.6	0.0	3.7	0.9	0.5	0.0	21.5	0.9	0.0	0.9	13.9	0.4	0.0	0.4	2.6	54.6	17.8	0.1	0.3	0.3	0.3	0.0	0.1	0.6	3.7	0.3	10.6	0.2	0.1	1.2	1.0	2.1	0.2	0.2	0.0	6.4	27.9	18.1	0.0	28.3	0.0	3.0	21.7	0.0	0.0	0.2	1.3	28.5	0.0	0.2	1.0	0.9	2.2	11.5	0.7	0.1	13.8	16.7	25.5	12.5	18.2	16.6	15.1	34.5	9.7	19.4	31.5	17.9	15.0	4.7	1.2	3.3	17.2	38.7	38.2	6.7	10.3	15.7	3.9	0.9	14.9	40.8	1.2	4.7	11.8	0.0	3.4	1.1	7.0	1.3	1.1	15.5	128.5	35.0	11.1	8.0	63.6	3.2	9.8	81.9	8.5	389.5	8.7	247.8	4.1	14.0	2.1	98.2	13.3	25.8	17.6	0.3	0.9	1.5	2.2	6.4	16.6	0.5
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.3	6.4	7.8	7.6	5.0	6.8	3.1	6.5	6.2	7.3	6.4	10.7	6.3	14.9	6.7	7.8	5.0	8.1	10.4	7.8	9.6	7.4	6.7	10.3	11.8	4.2	5.8	5.4	8.6	6.2	6.2	8.3	19.0	8.2	11.8	10.2	9.1	12.0	7.3	7.0	9.3	9.8	3.0	10.6	4.2	8.7	18.5	8.1	4.7	8.7	3.5	6.3	8.8	6.7	14.2	6.5	8.4	7.0	7.8	12.2	10.3	7.6	5.8	8.7	4.5	17.7	2.4	6.0	7.0	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9	8.9	10.7	13.0	26.3	17.6	51.9	2.8	2.5	5.3	7.9	3.5	49.1	5.0	5.0	8.8	2.2	11.7	6.7	0.0	9.5	5.0	9.3	37.6	6.9	11.0	7.6	35.0	11.5	8.6	10.7	2.2	6.9	9.2	10.1	1.8	7.8	33.2	9.1	5.8	9.9	9.1	32.5	25.8	15.1	10.4	10.9	16.3	6.8	16.6	9.7	39.6
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 83.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	21.1	17.1	13.9	14.1	19.2	15.4	20.7	16.7	17.3	14.5	13.8	9.0	10.3	10.3	15.4	12.1	19.2	15.8	14.4	19.6	16.5	11.0	18.8	30.7	12.2	15.3	16.8	11.3	20.9	25.9	13.7	21.6	15.5	19.3	15.5	14.1	9.5	14.0	11.5	46.3	16.7	10.6	19.8	17.4	16.3	14.2	18.1	18.7	10.0	20.4	29.3	15.8	22.1	15.1	10.3	9.3	0.8	7.7	11.1	12.4	6.1	8.0	3.9	4.4	17.4	7.7	12.1	11.6	11.6	6.9	10.3	10.3	15.7	5.9	19.0	11.1	5.8	15.3	9.2	14.6	11.0	23.4	8.0	13.4	12.4	4.9	9.1	9.3	18.8	6.0	7.3	8.8	14.3	29.3	6.9	8.2	8.8	33.0	10.5	12.9	7.8	13.9	19.8	12.8	13.1	7.1	13.3	8.4	13.5	9.9	8.1	7.5	9.7	5.1	6.8	19.1	6.6	6.2	16.1	5.3	8.5	7.5	83.2	31.0	4.5	7.0	23.7	11.3	23.8	17.1	0.3	6.9	0.8	5.9	7.7	12.4	10.3	8.4	7.7	8.1	7.8	11.1	10.5	0.2	11.1	4.9	9.3	7.3	6.1	13.9	19.2	16.7	17.3	16.5	11.0	16.8	11.3	19.3	18.7	17.9	26.9	21.2	94.7	69.6	12.6	61.4	45.9	61.6	63.7	17.4	0.0	40.8	58.0	40.9	72.5	33.0	12.0	0.0	41.1	44.2	40.8	42.1	44.0	66.6	48.0	17.5	10.9	22.7	27.3	20.4	31.9	26.8	35.4	18.0	26.8	18.6	37.2	21.0	25.5	70.4	8.2	12.9	35.4	37.2	27.3	58.0	28.9	17.9	32.7	65.4
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	45.1	91.1	38.6	64.9	173.7	316.0	68.1	55.1	113.9	85.4	66.3	100.7	79.3	178.9	62.9	131.3	40.4	82.2	275.6	213.2	94.6	49.4	165.2	109.6	81.7	83.7	244.9	114.8	54.9	310.0	278.0	92.8	371.0	105.2	136.6	84.9	100.3	70.4	127.7	74.5	76.4	51.1	84.4	100.9	65.3	85.8	88.0	173.6	117.4	89.7	68.6	71.7	34.0	96.8	136.2	84.5	71.5	166.0	80.0	44.7	67.5	41.5	87.6	69.2	107.3	119.6	55.0	154.6	50.2	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0	419.9	882.0	1803.2	2287.0	2152.7	118.6	357.6	588.5	738.8	1063.5	324.5	76.6	1844.2	1399.3	929.4	510.9	791.2	291.1	327.1	1855.6	3103.9	1180.5	1227.4	901.9	616.8	1082.4	38.1	731.3	578.2	1045.6	1022.7	1235.2	1320.8	1032.5	1779.1	995.5	130.7	1271.8	480.5	936.2	1212.4	111.6	452.7	1291.3	308.9	412.0	2258.1	2005.7	1400.6	1218.5	2270.0
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	118.8	51.1	91.0	76.7	118.4	239.2	146.0	71.1	95.2	88.5	63.5	135.2	52.0	224.2	114.2	79.8	84.0	76.0	104.3	133.2	113.2	71.0	142.8	116.3	85.0	124.4	142.0	178.1	49.1	195.6	210.2	78.6	173.1	160.6	122.3	118.5	144.0	118.2	101.4	67.4	141.8	201.9	140.6	90.4	96.5	130.3	176.3	144.8	107.4	99.0	77.6	92.9	46.3	129.2	206.7	78.2	71.2	245.0	74.2	44.7	81.8	84.6	128.1	73.2	69.5	151.7	30.3	153.6	30.3	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7	607.4	848.7	2690.4	3540.6	2525.4	316.8	352.2	1200.0	674.6	1189.7	390.8	84.4	2237.8	1689.4	1278.7	1159.8	1643.6	564.1	537.3	2338.5	3530.6	1572.9	2535.7	1002.7	856.3	1297.7	138.2	1189.1	1198.2	1468.3	888.7	2620.2	1565.9	1334.5	1646.5	1585.6	343.0	1936.2	1164.3	2027.0	1766.3	226.7	1034.8	1885.9	531.9	457.4	2528.9	2185.2	1965.9	2487.8	3230.9
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.6	19.1	20.0	24.1	13.0	14.1	7.1	20.5	18.5	34.4	36.1	32.2	23.1	16.9	15.7	13.0	22.4	20.1	26.6	18.2	35.5	27.1	18.3	11.4	12.2	25.4	12.4	23.0	14.4	11.5	11.9	25.9	29.4	14.5	19.4	15.6	22.6	15.5	22.7	17.7	26.6	31.3	12.4	16.3	21.7	14.9	17.1	17.8	12.9	13.6	10.9	10.9	12.0	8.7	24.1	19.2	23.5	14.6	11.0	17.2	17.2	9.7	42.3	10.5	26.8	36.3	21.5	12.5	13.1	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6	29.8	20.0	24.7	27.9	30.6	18.6	39.9	22.9	17.4	20.5	14.0	17.7	50.9	26.6	34.6	73.2	18.4	8.7	0.0	30.3	55.9	20.4	16.0	23.1	12.4	49.9	15.9	19.0	20.3	22.6	37.3	26.7	27.6	21.9	32.5	17.8	20.3	27.7	14.0	27.6	27.1	20.1	38.8	28.1	53.2	47.3	29.6	28.3	27.3	17.5	21.8
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.9	21.4	5.7	12.3	4.4	5.2	12.5	10.1	6.1	10.5	8.2	23.2	14.8	17.6	13.2	6.4	9.4	20.6	15.6	11.7	7.1	9.6	18.7	13.6	8.0	18.0	7.3	21.1	17.9	5.4	16.6	25.8	23.9	11.9	5.9	9.9	19.4	11.8	5.9	20.8	14.3	13.6	24.5	8.5	14.5	15.7	7.8	17.4	7.3	8.9	7.7	16.4	8.1	7.8	10.1	4.6	18.8	11.0	7.7	7.1	12.2	15.8	31.9	24.2	21.0	20.7	10.1	27.2	7.5	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1	32.8	39.8	13.7	10.9	20.8	6.2	9.5	7.6	25.4	34.2	14.0	39.3	4.4	0.0	9.1	5.6	6.7	3.9	0.0	7.4	5.9	7.6	10.1	39.4	6.8	10.4	4.8	20.6	4.9	10.8	3.6	3.4	8.4	6.8	1.0	7.2	2.2	7.8	5.1	2.5	6.8	12.3	0.0	6.1	9.9	18.4	17.1	7.7	4.4	7.8	12.4
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659548-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	12.7	10.3	10.7	20.0	13.7	7.6	14.5	13.9	12.5	13.1	11.1	11.5	9.4	9.5	16.1	9.2	15.7	14.0	12.2	8.4	9.5	8.6	7.5	17.7	10.4	22.8	13.1	7.5	20.0	20.6	11.8	11.4	8.4	10.3	11.3	10.9	15.0	13.9	12.8	21.6	14.1	11.1	12.9	9.9	16.9	11.8	32.5	12.6	25.6	9.6	12.6	20.5	13.5	14.1	6.0	3.2	2.1	2.7	5.8	9.8	5.3	16.9	10.0	10.7	16.1	7.0	7.5	8.8	8.9	6.4	9.9	8.2	22.7	7.4	33.2	5.9	7.0	11.5	7.6	26.4	15.4	11.8	11.1	21.0	19.6	11.6	14.2	9.7	30.5	7.8	7.7	9.9	11.9	13.8	6.1	11.0	14.4	30.6	9.8	8.7	8.8	24.2	9.3	36.5	11.0	11.2	32.0	10.8	23.2	7.2	8.1	21.3	11.4	16.8	12.4	12.4	4.1	8.1	9.6	9.8	3.1	9.7	8.1	16.2	13.3	16.9	39.7	9.7	33.0	10.0	2.1	2.6	0.7	7.2	2.7	8.5	6.0	9.1	8.6	3.2	5.3	8.6	9.8	0.1	5.8	2.3	2.6	7.0	5.3	10.7	13.7	13.9	12.5	9.5	8.6	13.1	7.5	10.3	12.6	29.8	16.0	22.1	12.1	20.3	28.9	10.4	12.7	21.4	28.4	5.2	123.7	6.5	1.7	12.9	195.5	15.9	4.7	0.0	13.7	13.6	13.6	12.0	33.7	16.6	16.5	23.8	5.2	11.1	11.9	173.7	20.8	11.6	8.5	11.8	8.5	14.7	16.6	0.0	25.1	9.5	138.2	0.0	16.0	24.0	34.2	27.7	3.7	27.3	13.8	12.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 714.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 94.7;SuSa: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	21.1	17.7	20.5	13.0	18.1	53.1	7.4	29.4	46.6	17.8	20.5	17.2	23.6	0.5	55.9	49.8	2.6	20.2	8.5	18.2	15.8	0.0	7.9	1.3	22.2	14.6	12.0	0.6	4.6	42.7	6.9	15.9	17.2	52.5	40.2	0.1	6.8	0.0	55.3	74.9	0.0	0.3	16.5	18.2	53.5	3.3	21.2	0.1	94.7	16.2	6.3	0.2	62.8	32.4	63.5	111.1	26.4	0.7	56.9	12.3	6.9	16.4	35.3	0.2	0.5	0.9	22.0	0.3	7.2	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5	26.8	88.4	17.1	154.8	98.1	2.0	108.1	175.8	60.2	93.3	441.4	0.0	118.0	210.5	277.9	6.5	300.3	126.3	46.7	281.2	170.7	294.9	188.4	23.1	34.1	128.8	0.0	119.8	371.4	32.4	21.5	714.6	43.9	226.0	20.8	107.7	97.5	336.0	115.8	295.2	330.9	5.7	0.0	84.3	7.5	18.3	66.1	62.5	8.6	64.8	157.7
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Cell type enhanced"	"Detected in many"	20	"Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 671.5;RT4: 262.5"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	25.4	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.5	0.5	0.5	63.2	0.0	671.5	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	89.4	0.7	102.0	0.7	0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.6	4.9	0.0	16.0	0.0	15.9	262.5	0.5	0.0	1.1	0.1	0.2	0.2	0.1	0.1	0.1	0.4	22.2	2.9	8.6	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4	8.9	15.9	2.2	2667.8	10183.7	0.0	2.0	2.5	307.9	1714.1	207.6	0.0	0.1	1039.5	26.2	3.0	3.6	1.3	0.0	24.2	0.9	117.2	609.3	16.2	0.0	1.8	0.0	1.7	0.6	1.5	3.8	0.6	38.5	720.4	9.0	1.7	1.0	390.7	2.9	0.7	9.8	0.0	0.0	213.2	0.2	2.3	3170.0	0.2	1.3	1.5	4604.3
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Group enriched"	"Detected in some"	14	"Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1"	"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	15.2	0.1	0.4	0.3	0.0	5.0	12.9	0.3	0.7	0.0	0.0	0.0	5.8	7.1	4.5	0.0	9.4	0.0	0.4	0.0	5.7	0.0	0.0	9.1	0.3	0.0	4.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	1.8	0.9	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	24.1	0.0	5.0	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4	0.0	0.0	0.0	0.0	0.2	0.0	1.1	7.6	0.0	0.0	8.7	23.6	0.0	10.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	27.2	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	16.7	0.2	0.0	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.1
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006575			Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	"Centrosome, Cytosol"	"HPA006575: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.3	6.1	9.8	8.8	8.3	9.9	7.8	8.5	9.1	9.3	15.0	10.6	5.3	12.5	23.8	9.3	15.9	9.2	10.1	4.5	15.1	6.7	6.6	16.9	9.1	7.4	9.6	14.0	8.0	8.5	12.3	9.5	10.1	6.7	9.0	11.2	11.2	19.4	10.8	11.5	13.1	8.2	7.6	7.3	12.0	8.5	7.9	8.5	4.5	7.6	6.1	8.1	9.5	10.8	10.5	10.3	18.1	10.7	10.1	9.1	9.3	12.4	17.4	20.8	36.3	27.0	12.2	11.3	10.3	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4	20.8	13.0	17.1	20.7	54.0	26.0	12.5	10.2	9.4	14.8	8.7	15.7	15.8	10.0	14.8	27.7	20.4	12.4	0.0	12.2	12.8	21.0	19.3	25.5	16.6	12.0	27.0	20.7	13.5	16.1	36.8	15.0	18.8	13.5	14.4	13.2	15.4	20.6	17.5	15.6	14.7	27.7	25.8	24.0	36.7	40.5	54.3	19.1	26.7	10.1	28.1
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 1164.8;Sertoli cells: 802.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"		Yes	No		16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.1	17.4	44.5	29.2	50.2	51.9	22.8	46.7	43.1	39.9	34.4	27.0	28.1	34.3	31.7	47.5	53.6	27.5	31.4	31.1	57.0	23.4	16.5	27.6	24.4	14.6	29.3	33.2	30.5	33.6	24.4	31.3	30.9	41.8	41.5	27.1	21.6	27.1	64.7	16.9	33.5	55.8	47.7	33.9	24.7	34.6	42.4	19.7	38.6	27.0	23.9	42.0	32.6	42.0	27.9	76.2	31.0	36.8	35.0	40.3	47.8	24.7	51.4	32.0	29.1	86.5	25.7	55.6	85.0	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2	142.9	97.9	186.4	0.0	141.0	199.4	207.8	40.8	222.1	184.2	129.1	43.2	148.6	127.6	0.0	342.3	214.2	64.6	23.3	0.0	161.3	239.6	0.0	368.3	69.5	168.4	1164.8	58.6	187.2	128.6	256.8	324.7	171.1	178.8	0.0	61.0	328.2	0.0	106.6	426.0	108.1	113.7	802.0	509.2	101.6	233.2	140.9	103.9	294.1	77.5	0.0
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 36.2;Kupffer cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.3;MOLT-4: 26.5;SK-MEL-30: 15.2;U-2197: 11.5"	"Low region specificity"	"Detected in many"							"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	16.8	4.2	3.7	12.7	7.6	7.5	8.5	0.9	4.0	5.7	3.2	8.6	3.3	1.9	3.2	7.9	9.7	3.9	10.0	4.5	6.6	3.5	19.9	11.2	10.1	14.2	7.4	1.0	2.8	8.6	1.1	3.3	5.8	7.2	5.9	2.4	6.4	5.9	6.0	2.0	3.3	5.6	4.1	9.6	17.0	9.6	1.7	5.8	24.4	5.6	3.8	14.5	9.9	6.3	6.5	14.5	1.0	8.6	0.4	2.0	2.6	2.2	3.5	0.1	0.0	0.0	0.4	2.6	0.2	0.2	0.3	0.5	1.8	1.3	3.1	3.0	0.0	0.5	1.3	0.0	6.6	0.0	8.1	0.1	0.0	2.8	2.9	2.6	0.0	0.4	0.1	8.2	0.1	6.7	0.2	15.3	2.0	0.4	4.3	0.3	2.5	26.5	2.1	0.1	1.3	2.9	1.7	0.9	0.9	0.3	0.4	0.2	1.4	1.0	0.3	15.2	1.0	0.0	0.5	6.2	0.0	1.8	11.5	0.2	0.1	0.6	2.7	0.1	1.2	2.0	0.0	7.5	1.0	0.7	6.9	0.7	4.2	1.5	0.9	6.2	6.5	0.7	0.6	0.2	0.4	8.6	14.5	2.0	2.6	3.7	7.6	0.9	4.0	6.6	3.5	7.4	1.0	7.2	5.8	0.0	8.0	7.4	10.1	0.7	0.8	2.8	7.6	1.4	3.4	24.4	0.0	1.8	6.6	3.2	0.5	6.9	0.2	0.0	4.8	2.7	1.7	4.0	17.3	7.3	19.3	22.3	1.2	36.2	27.9	1.0	0.6	18.1	0.0	5.4	0.9	18.4	7.4	2.9	0.7	12.5	0.6	0.0	2.1	0.0	0.0	0.5	2.5	6.9	1.2	15.7
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638097-65650930	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	10.5	9.1	7.5	27.1	12.0	29.8	10.0	2.6	8.7	8.9	10.8	9.4	2.9	7.7	10.9	3.0	7.6	9.0	9.9	8.0	8.4	4.6	9.5	7.8	17.6	33.2	11.5	4.7	7.7	4.6	2.7	4.2	11.9	10.3	8.6	3.9	8.2	8.7	6.8	5.4	4.2	17.2	9.0	14.3	47.1	8.1	3.0	10.5	25.3	7.7	4.6	32.7	8.5	7.8	6.6	2.8	14.1	5.2	5.8	7.4	3.0	0.7	6.2	4.5	9.6	2.6	5.5	10.6	7.2	6.1	5.6	5.5	1.9	6.9	9.9	16.2	3.5	0.2	3.6	1.6	2.4	1.9	10.7	4.0	24.2	9.2	3.4	4.7	9.8	10.5	5.6	1.1	7.8	1.0	5.6	16.4	10.4	13.7	4.6	2.8	2.7	3.9	16.7	3.0	2.5	5.8	17.8	2.5	8.8	2.1	0.5	1.7	10.3	3.5	6.1	14.6	4.3	4.6	15.1	23.0	6.9	14.1	7.6	1.4	6.9	5.4	22.3	9.5	15.6	20.1	4.0	4.1	10.2	7.4	4.8	5.5	5.3	3.7	4.8	2.8	6.6	2.9	4.4	14.1	5.8	5.2	2.7	3.5	3.0	7.5	12.0	2.6	8.7	8.4	4.6	11.5	4.7	10.3	10.5	6.0	6.9	45.9	21.9	6.1	1.7	3.7	25.5	0.0	2.3	22.7	0.0	7.8	31.5	18.4	2.6	16.8	17.3	23.3	13.0	17.8	8.2	22.9	6.9	19.8	31.9	4.8	20.2	39.9	38.3	5.4	7.5	26.7	10.1	10.8	11.7	4.8	23.9	11.5	12.4	14.6	1.6	12.9	14.0	0.7	17.9	9.7	11.3	33.2	11.4	27.8
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Group enriched"	"Detected in some"	18	"Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9"	"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	8.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.1	0.7	2.4	1.4	0.0	0.1	3.8	0.0	0.3	1.5	0.2	0.0	19.0	9.9	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.2	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	29.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.3	18.7	9.4	0.1	0.1	0.0	0.0	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 261.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 10.0;SuSa: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	10.0	0.1	0.1	0.0	0.1	0.0	0.9	3.7	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0.0	1.1	0.5	0.0	0.0	0.2	1.3	0.0	1.4	0.0	17.4	2.0	0.0	41.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.7	0.0	0.0	0.0	0.6	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.2	0.8	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027408-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"granulocytes: 8.1;Intestinal endocrine cells: 7.5;monocytes: 12.6;Undifferentiated cells: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.9	13.6	17.1	12.7	18.3	11.6	23.5	25.7	21.9	13.2	22.7	16.7	9.5	19.7	14.2	8.9	15.9	11.4	13.9	15.1	16.2	14.3	15.7	9.8	14.1	14.7	16.3	14.5	18.3	17.7	13.7	8.4	9.5	13.4	15.1	11.6	11.2	15.6	15.4	25.2	17.2	20.4	15.0	17.6	11.3	13.5	7.6	15.8	12.4	14.4	10.1	11.5	14.9	12.5	7.7	8.0	10.9	18.3	3.2	7.1	5.7	17.4	12.9	8.4	8.2	10.2	7.5	4.7	1.7	7.9	13.8	12.7	10.2	13.7	17.8	9.9	10.0	17.4	9.8	9.8	8.7	3.8	26.8	8.1	8.9	10.6	17.0	11.0	4.6	14.4	6.3	13.1	14.6	8.5	7.7	8.2	13.1	15.0	11.4	7.2	10.5	16.3	20.7	9.1	6.8	12.8	13.5	5.0	19.2	10.2	3.8	15.2	11.5	14.9	13.5	12.9	4.0	13.7	10.7	16.1	14.0	13.5	14.1	7.4	12.3	21.1	17.0	13.7	7.3	4.8	7.8	11.3	10.9	6.9	13.6	5.6	7.7	7.1	6.1	8.0	6.1	5.2	4.7	1.6	3.2	18.3	5.5	6.7	5.7	17.1	18.3	25.7	21.9	16.2	14.3	16.3	14.5	13.4	15.8	0.0	3.5	0.0	0.0	0.9	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.4	4.2	0.0	2.7	0.4	0.4	0.0	8.1	0.0	0.9	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	12.6	3.1	0.2	3.5	5.1	0.4	0.5	0.4	0.0	0.3	0.0	0.0	0.4	0.3	1.0	6.0	0.0
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0	0.0	0.0	0.0	4.5	4.9	0.4	1.0	0.0	0.0	3.4	14.0	0.0	0.0	24.9	0.0	14.4	0.2	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	28.6	2.4	0.6	0.0	9.4	6.6	0.0	30.4	0.0	0.0	15.0	0.2	0.0	2.5	14.4	0.4	0.0	0.4	2.7	0.9	6.4	0.0	0.0	2.1	0.3
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Group enriched"	"Detected in some"	7	"A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	41.8	1.0	0.6	0.3	0.0	0.1	3.2	0.5	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	0.1	47.0	0.0	18.8	0.1	1.1	1.3	0.1	0.5	0.1	0.0	0.1	0.9	0.0	18.6	0.2	4.2	1.3	0.0	0.8	0.9	0.3	0.0	0.3	0.2	0.5	1.3	0.1	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	1.9	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.5	0.6	1.5	0.6	1.1	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0	0.0	0.0	0.0	39.1	185.8	11.0	2.8	0.0	10.7	5.7	1.8	13.7	0.3	1.7	0.0	0.1	1.6	0.2	0.0	0.4	1.5	6.1	15.1	0.0	0.0	0.4	9.5	1.2	1.8	2.7	0.6	29.1	1.1	25.3	1.8	0.0	33.2	0.3	0.0	34.6	0.0	6.2	32.3	8.9	0.4	8.7	148.4	0.9	0.0	0.2	76.9
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 163.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Group enriched"	"Detected in some"	35	"EFO-21: 42.0;RPTEC TERT1: 118.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	118.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3											0.0	2.9	10.4	12.6	0.0	8.9	1.2	2.5	1.4	0.0	0.0	2.0	2.6	3.3	3.3	1.3	1.0	19.8	0.0	1.8	3.1	18.3	5.0	2.3	0.0	1.6	1.6	16.0	3.7	0.3	1.2	4.0	0.0	0.0	0.0	18.6	163.5	4.5	10.5	28.3	0.8	29.7	6.5	5.4	0.2	0.6	0.0	4.1	5.0	35.1	8.0
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin-like modifier 1"	P63165	2	202206180-202238608	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	27.1	37.8	44.4	21.6	37.9	41.8	31.6	47.7	49.2	26.9	29.7	19.9	27.2	26.2	24.7	33.4	26.9	24.7	26.6	28.3	38.0	39.6	43.5	62.6	24.6	28.7	34.6	40.6	23.4	29.8	26.6	28.7	30.4	32.3	28.8	31.2	21.6	35.6	24.5	42.4	21.6	33.2	27.6	29.6	25.1	26.4	28.7	27.1	32.2	38.4	28.1	33.6	26.9	23.1	74.8	63.0	77.0	63.7	65.8	89.0	94.0	33.7	17.1	62.4	33.1	34.8	37.2	27.9	35.9	45.4	44.8	59.5	36.8	43.0	23.1	33.4	41.4	41.9	24.7	51.1	49.9	70.5	21.6	39.2	42.7	33.6	43.2	25.2	48.1	40.7	28.6	48.3	35.1	26.8	42.2	41.7	46.2	39.3	37.6	47.9	28.7	60.5	80.0	75.0	34.8	36.4	39.2	35.0	40.7	54.3	28.1	43.4	47.4	29.3	28.5	48.0	70.7	25.6	46.1	29.2	33.1	33.4	30.3	31.7	32.8	64.7	58.6	36.9	34.3	29.0	56.6	63.7	77.0	51.1	62.6	53.5	74.8	63.7	59.8	63.0	58.4	60.2	62.8	73.6	65.8	62.8	52.9	89.0	94.0	44.4	37.9	47.7	49.2	38.0	39.6	34.6	40.6	32.3	27.1	104.2	49.5	141.2	176.9	375.0	93.7	54.1	96.8	83.0	78.5	179.7	60.9	228.3	407.8	216.2	44.0	153.6	150.3	46.7	152.2	246.7	239.6	215.1	91.1	181.0	182.5	82.6	136.7	118.4	134.8	20.6	120.3	156.9	200.8	294.0	123.6	118.9	175.8	178.5	120.2	378.6	73.5	109.9	205.0	172.2	119.7	371.1	175.4	191.9	139.7	207.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.4	5.0	7.4	3.1	2.9	8.3	6.5	3.9	5.8	3.7	10.1	7.1	11.9	5.1	3.6	4.3	12.5	6.4	6.9	2.2	7.9	7.2	8.2	7.4	6.0	5.6	13.8	7.1	4.1	6.1	6.1	5.7	5.3	3.0	11.7	17.8	6.5	5.2	10.7	11.2	11.4	14.5	16.8	11.7	11.8	6.9	12.1	5.1	4.0	10.5	8.9	6.4	10.5	5.7	3.2	9.2	7.8	6.2	13.4	7.1	6.7	8.9	4.8	6.8	15.5	5.0	9.5	7.8	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8	41.7	23.5	25.1	10.6	21.1	24.6	26.3	30.6	17.4	35.2	21.0	5.9	26.9	18.3	29.0	1.1	20.3	37.7	0.0	16.8	19.1	14.3	11.8	24.3	29.2	18.5	20.6	32.3	12.9	11.1	2.4	25.6	14.2	6.8	21.6	37.2	16.4	23.6	28.1	26.2	11.9	20.1	0.0	17.0	18.9	21.0	24.1	15.9	16.6	47.0	10.5
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.3	12.7	12.0	13.7	6.9	8.9	12.3	14.0	12.4	17.2	20.8	9.6	8.1	31.3	10.8	8.7	14.7	12.7	17.8	8.0	28.0	11.0	17.3	21.7	10.8	6.9	8.2	34.1	22.3	6.2	9.1	17.1	13.2	10.4	10.5	15.0	20.9	43.6	14.7	5.0	40.5	19.8	6.8	10.1	7.8	24.2	30.8	25.4	10.1	14.0	15.4	12.0	22.5	7.3	13.5	8.7	21.1	28.5	7.7	13.7	12.5	16.3	21.5	23.8	29.6	38.8	10.0	21.1	12.3	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5	38.7	37.9	23.1	41.1	52.0	74.2	24.8	35.7	28.1	37.5	33.2	102.1	49.4	14.9	23.6	8.9	34.9	15.6	23.3	19.1	45.9	33.8	46.2	15.1	37.5	27.9	58.8	28.3	38.6	41.9	10.7	24.7	37.6	23.6	86.6	31.9	41.7	22.6	10.5	24.1	24.5	76.3	12.9	32.5	100.7	141.1	62.7	58.1	39.9	33.0	48.2
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.9	3.1	4.2	4.2	4.1	16.2	7.6	4.4	3.3	5.7	4.1	10.6	10.7	9.5	8.5	4.3	1.9	11.7	4.9	6.9	6.3	2.6	2.0	9.7	17.5	6.3	4.1	8.8	5.2	4.5	7.5	4.5	7.4	9.0	7.1	5.0	6.6	18.8	7.8	1.2	7.4	17.0	3.2	2.9	2.4	3.5	4.7	8.1	6.5	6.3	3.0	6.3	2.6	9.6	3.0	6.1	11.9	2.2	6.9	8.6	5.7	12.9	6.5	8.4	9.5	8.0	3.1	9.4	2.9	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6	83.4	80.4	125.3	241.5	216.9	84.2	23.0	129.9	91.0	139.9	27.9	37.3	149.3	38.1	80.3	12.9	79.2	61.0	0.0	125.2	151.7	105.8	205.9	100.6	46.5	62.1	65.2	105.6	52.2	91.2	12.3	119.0	105.3	75.9	66.7	101.9	39.6	109.2	66.6	63.6	64.8	75.6	71.1	94.7	37.0	70.9	177.4	134.6	106.5	115.9	265.8
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	38.7	54.0	76.1	41.7	82.7	72.5	49.8	41.7	55.8	35.3	49.0	22.6	44.7	37.8	28.4	72.6	43.0	30.5	40.3	49.8	61.4	61.6	50.3	50.3	36.6	50.3	63.6	46.0	41.7	59.5	21.6	45.4	28.7	53.3	36.9	47.0	39.2	39.6	37.4	107.4	28.4	41.1	36.5	57.4	41.5	39.0	35.0	41.0	37.9	38.3	67.6	56.6	29.9	37.7	125.7	139.0	192.1	98.7	79.4	146.7	204.3	65.2	47.4	76.9	55.0	63.8	62.3	53.0	54.0	42.6	51.8	51.5	38.5	47.3	42.7	38.6	46.9	67.6	25.6	67.0	60.9	57.9	52.5	57.1	80.5	102.1	98.1	49.7	91.3	54.0	57.0	65.5	48.9	47.7	50.8	65.3	76.4	43.0	45.7	73.8	67.6	106.2	124.3	102.5	71.0	76.5	30.4	48.2	72.3	89.0	88.5	25.3	64.3	60.8	44.5	81.2	74.5	42.9	135.7	48.8	44.0	79.1	67.9	105.3	76.3	112.4	102.9	56.4	88.3	45.5	141.0	98.7	192.1	110.7	89.8	119.5	125.7	146.7	132.9	104.9	100.5	146.3	140.0	188.5	79.4	87.7	139.0	143.8	204.3	76.1	82.7	41.7	55.8	61.4	61.6	63.6	46.0	53.3	41.0	223.4	369.4	511.1	446.0	636.3	196.3	594.9	570.7	348.0	349.2	854.9	100.1	706.5	1455.6	502.0	547.1	428.3	899.7	443.9	893.2	693.8	535.7	516.2	437.2	865.9	741.4	112.8	610.5	535.9	636.7	794.0	598.9	617.4	737.2	776.3	895.2	244.7	727.5	821.9	436.7	886.4	223.1	349.3	415.1	507.5	743.5	785.4	368.1	657.2	795.4	485.3
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.8	4.0	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.3	0.0	0.1	1.8	0.0	0.0	0.0	2.3	0.0	0.5	0.0	10.3	45.3	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.9	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3	3.0	2.9	0.0	0.5	2.2	11.4	1.2	0.0	0.0	9.1	0.0	96.2	1.8	0.0	0.0	57.1	1.4	0.0	0.0	0.3	7.2	1.1	0.2	1.1	0.0	0.2	1.6	0.0	0.0	0.0	29.1	0.9	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.7	0.0	56.3	0.0	1.4	19.1	8.0	1.4	0.9	0.0	0.0	0.3
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 76.6;Spermatogonia: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.7	4.8	9.3	4.8	5.5	7.8	6.7	8.2	3.2	5.8	4.3	3.9	8.4	9.3	3.2	4.8	5.2	3.9	10.8	5.2	8.9	11.8	4.8	6.4	4.1	6.4	5.3	16.2	6.9	4.9	13.4	5.8	12.7	3.4	5.8	8.5	14.7	8.4	4.9	7.8	13.6	3.3	5.5	12.1	4.6	7.9	8.9	5.9	7.8	5.5	5.8	5.1	4.5	24.9	8.2	8.1	8.1	7.0	4.2	5.9	6.1	4.8	9.3	5.8	9.8	8.5	4.5	9.5	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1	3.0	9.3	6.0	5.1	7.2	4.6	5.9	12.7	20.1	4.5	10.4	3.9	14.6	36.5	11.9	34.0	6.7	10.7	0.0	16.6	14.7	5.4	5.0	8.1	24.2	7.1	4.8	6.9	9.2	7.9	11.7	6.1	4.7	5.0	5.4	9.8	7.8	14.8	11.0	7.1	17.0	5.9	12.9	7.1	76.6	51.2	8.3	14.6	4.8	9.6	5.9
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.3	26.1	19.1	17.4	17.3	12.5	17.1	20.2	16.5	18.9	16.2	24.6	22.3	22.3	14.0	17.7	33.7	21.1	46.7	28.0	25.2	29.0	23.1	18.2	19.5	19.2	10.7	31.4	19.0	11.6	15.4	26.3	27.2	14.9	13.1	18.8	18.5	16.7	19.2	37.4	23.9	24.8	30.4	18.4	29.7	21.5	35.6	18.9	20.1	18.1	24.2	16.8	38.5	19.3	21.4	34.7	39.2	11.0	17.9	13.9	24.5	29.1	17.2	17.9	27.0	26.7	20.4	25.0	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5	23.8	23.8	40.1	37.8	29.1	55.8	44.8	22.9	45.5	39.8	33.2	25.5	86.7	106.1	35.8	0.8	36.5	26.0	0.0	28.8	60.7	42.6	34.1	43.9	22.9	39.7	54.0	17.4	23.4	12.3	2.1	32.2	27.9	38.8	70.3	30.8	56.3	30.9	28.6	42.5	51.9	48.8	45.3	43.4	12.2	43.7	27.7	63.5	41.1	28.8	29.1
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.5	39.3	19.9	18.9	10.6	12.7	14.5	22.5	19.8	16.3	14.1	23.7	16.8	22.7	17.0	15.9	32.7	14.1	22.1	22.2	12.3	25.8	134.3	33.0	25.3	15.4	26.0	29.8	26.2	13.6	17.4	24.8	29.5	17.9	19.6	21.5	16.0	28.7	21.6	22.1	23.8	27.1	12.6	25.2	34.4	22.2	16.6	29.2	18.8	27.2	35.1	28.7	19.5	23.9	21.0	7.6	14.3	27.4	14.6	51.1	10.4	16.0	39.8	34.8	52.5	24.3	32.5	26.5	33.3	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1	6.0	15.4	10.4	28.7	35.8	101.5	34.7	17.8	12.0	6.8	17.4	19.6	18.8	6.6	15.3	18.8	19.0	45.1	23.3	26.0	17.2	20.9	42.6	19.6	28.7	30.5	103.3	39.5	20.3	27.6	27.8	16.1	18.1	33.7	11.8	28.6	85.9	31.9	25.4	13.1	25.9	58.3	25.8	25.5	26.4	7.9	49.7	43.8	15.2	31.9	47.5
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18, small subunit processome component"	Q9Y5J1	17	51260528-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 146.3;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear membrane"	"HPA052378: AB_2681805"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	15.6	16.1	14.4	18.0	20.5	26.9	20.2	23.3	20.9	15.0	13.6	14.5	12.4	13.6	13.0	13.4	17.7	14.0	11.1	8.9	14.2	13.9	17.1	16.9	14.0	22.9	17.0	20.5	19.4	18.1	17.3	19.4	28.3	16.1	13.1	15.0	12.8	14.9	11.9	19.1	25.7	13.0	10.2	14.4	22.0	13.5	42.5	16.9	21.6	19.1	15.6	25.3	15.2	17.9	26.1	26.4	12.4	22.9	17.4	28.1	24.9	26.5	26.4	16.8	15.4	11.1	16.7	43.9	14.7	12.2	25.8	24.9	16.5	14.9	33.7	21.1	10.9	27.6	14.5	27.3	15.7	38.5	22.0	35.6	35.4	16.0	28.7	15.2	37.4	17.4	10.6	12.2	21.9	17.8	13.1	15.4	16.8	28.7	15.5	19.4	16.4	33.5	25.5	24.1	37.9	28.0	30.5	38.3	26.4	18.8	17.7	18.8	23.8	17.1	20.4	33.4	21.9	25.1	19.1	13.4	26.6	22.3	21.9	30.5	30.1	55.4	39.0	16.5	26.1	19.0	6.8	22.9	12.4	20.5	21.6	24.9	26.1	25.8	24.7	26.4	24.4	28.1	26.2	4.0	17.4	21.1	16.6	25.7	24.9	14.4	20.5	23.3	20.9	14.2	13.9	17.0	20.5	16.1	16.9	14.9	25.5	32.0	48.3	53.3	16.3	3.9	17.8	48.2	22.7	14.0	13.7	61.4	33.2	24.4	146.3	25.4	10.5	0.0	40.8	58.4	26.5	24.1	31.1	16.6	54.8	9.5	15.4	8.6	38.6	145.5	24.7	35.4	21.9	38.7	19.4	20.6	29.1	17.8	20.8	29.8	10.3	12.9	16.5	115.2	106.7	46.0	66.6	27.7	22.5	46.3
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.5	20.5	18.1	19.4	12.6	20.0	20.8	35.4	32.0	41.4	42.0	28.7	20.5	20.3	30.5	32.1	21.1	18.7	42.9	27.1	50.4	45.7	26.6	22.2	28.9	32.0	29.7	31.0	25.0	15.7	20.2	36.8	36.5	17.8	23.8	20.7	40.4	10.3	28.0	32.0	37.2	36.9	30.6	13.9	19.6	34.9	21.5	33.6	15.4	14.6	35.3	19.2	17.5	29.2	15.5	21.0	21.0	20.5	25.1	35.0	23.5	29.8	29.4	24.0	30.3	30.1	26.7	32.3	29.5	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8	8.9	13.9	21.7	8.2	16.6	23.8	6.6	2.5	9.4	10.3	22.7	29.5	9.8	6.6	13.3	27.6	10.6	14.7	0.0	16.4	13.9	12.4	15.6	2.3	14.0	19.9	20.6	22.7	8.6	23.4	30.6	10.0	14.7	6.8	27.1	21.5	8.3	18.1	14.0	8.1	5.0	26.3	6.5	11.3	29.5	29.2	18.6	7.0	20.8	17.0	12.6
Z82206.1		ENSG00000225528			22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	14	"blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 6.6;granulocytes: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 4.0;JURKAT: 3.2;K-562: 16.1;MOLT-4: 2.7"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.0	0.0		0.5		4.1	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.3	2.3			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1		1.0	0.1	0.0			0.0		1.1	0.3		3.6	3.0	5.7	2.2	2.2	8.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	16.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	4.4	5.2	2.2	4.5	3.6	6.5	5.7	2.7	3.2	6.7	8.1	4.3	2.2	1.9	3.0	4.2	7.6											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	13.4	12.9	16.4	14.6	16.9	23.8	13.5	22.3	24.6	14.8	30.0	20.2	15.9	30.5	15.3	14.2	22.2	13.1	22.2	11.6	16.2	13.3	20.0	28.5	15.2	27.3	18.8	17.9	14.1	29.1	18.6	18.0	22.2	15.6	14.7	18.5	11.3	17.3	14.2	15.9	23.4	34.7	24.5	17.5	22.6	21.8	9.5	13.9	23.0	30.0	12.9	19.3	14.7	16.6	29.1	20.5	36.6	27.8	30.7	32.5	25.4	10.6	7.3	8.3	11.7	8.9	9.4	11.6	10.8	12.7	15.6	15.5	16.3	9.1	8.6	11.5	18.4	12.7	7.4	7.7	13.7	12.5	13.3	12.0	19.8	12.0	14.1	18.2	10.5	22.9	7.7	30.2	15.3	36.6	8.8	10.4	19.1	11.5	24.6	15.2	18.4	17.3	22.1	4.3	14.8	8.4	10.8	5.0	14.8	14.7	9.0	18.2	8.2	5.2	8.8	12.0	9.8	7.5	22.3	11.0	15.7	14.8	18.1	15.3	10.2	3.3	15.5	15.4	20.8	12.2	17.7	21.7	28.6	32.1	27.8	28.0	25.4	29.3	31.3	16.4	29.1	26.7	32.5	36.6	30.7	21.9	20.5	30.2	25.4	16.4	16.9	22.3	24.6	16.2	13.3	18.8	17.9	15.6	13.9	20.8	26.3	36.4	21.1	24.2	13.5	11.1	25.5	8.1	9.1	19.2	13.7	22.5	48.0	34.1	3.4	27.0	133.2	0.0	57.4	20.0	23.7	23.5	32.3	35.5	29.9	7.9	38.6	14.7	29.1	5.5	29.7	26.7	33.7	13.6	57.3	20.9	46.6	94.7	28.0	57.5	14.9	25.8	33.0	5.7	13.0	31.6	42.9	46.7	47.7	24.8
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"		8	143246821-143262705	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	7.8	6.6	10.3	6.5	9.0	4.1	5.6	12.6	13.7	8.0	8.8	10.7	6.5	9.4	12.5	6.8	5.7	9.2	5.6	6.3	10.8	14.3	6.5	5.8	6.3	6.7	10.7	7.4	13.1	9.1	11.4	10.2	3.5	9.6	7.7	4.5	8.9	12.6	9.1	8.1	12.1	9.1	7.3	7.4	8.5	7.2	10.6	8.6	4.6	8.0	4.6	6.7	6.7	10.0	0.9	3.7	0.1	0.9	0.7	2.2	0.8	7.1	11.4	5.0	6.6	5.8	4.5	5.9	4.3	2.4	8.5	5.8	5.6	6.0	4.0	6.5	5.6	8.7	5.9	5.4	5.7	4.2	6.3	6.6	5.0	5.5	4.4	8.1	2.0	3.1	4.7	8.1	5.5	8.1	5.9	4.0	2.9	10.6	3.9	4.0	12.8	5.3	2.2	7.4	8.8	11.3	2.8	4.1	1.4	3.7	6.5	6.3	8.7	12.2	3.4	6.4	4.5	8.5	3.9	4.2	6.5	11.6	5.0	6.9	6.3	4.8	1.9	5.7	4.8	8.4	0.0	0.6	0.1	1.3	0.9	2.2	0.4	1.1	0.9	0.5	0.9	1.9	1.2	0.0	0.7	0.1	3.7	0.9	0.8	10.3	9.0	12.6	13.7	10.8	14.3	10.7	7.4	9.6	8.6	0.0	1.3	1.3	0.6	1.0	1.4	2.8	2.5	4.0	1.2	3.5	5.9	0.2	1.7	1.6	1.3	0.7	2.7	0.0	0.8	0.9	1.1	0.4	0.0	3.9	1.0	6.4	2.9	1.8	2.2	1.4	1.1	0.9	1.7	0.0	3.2	2.7	1.2	4.3	2.1	1.1	2.2	0.0	1.1	7.7	3.4	0.3	0.2	0.0	2.9	0.3
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.7	9.8	9.0	18.6	13.1	25.5	7.9	20.2	12.3	10.8	11.1	30.6	9.4	16.0	9.0	8.4	14.5	11.4	9.5	6.7	9.8	7.3	8.4	10.1	9.6	21.7	21.3	11.2	13.5	10.9	11.0	11.6	7.4	12.6	10.2	8.8	8.1	11.3	11.4	11.4	18.5	15.3	6.8	9.9	22.2	12.2	6.4	18.4	11.1	10.1	8.1	15.1	9.5	10.3	2.9	2.0	4.5	1.9	5.0	10.1	2.4	5.0	4.3	3.5	9.1	2.8	3.9	6.1	3.5	2.1	3.2	1.2	5.5	5.4	6.7	4.4	3.7	1.6	9.4	4.4	3.9	2.4	4.1	23.5	6.0	8.0	2.1	5.5	5.8	7.9	5.4	5.2	4.3	3.6	3.2	4.9	6.0	11.0	5.7	1.5	7.1	7.3	13.3	2.6	5.0	9.6	11.8	3.8	4.5	4.0	3.0	9.5	8.0	7.6	6.9	4.2	2.2	9.3	8.4	5.5	5.4	7.3	4.2	3.0	20.8	6.7	3.5	4.3	9.7	5.3	4.3	1.7	2.8	10.1	1.9	4.8	2.0	5.5	7.6	1.8	2.9	5.6	7.2	4.5	5.0	1.2	2.0	4.0	2.4	9.0	13.1	20.2	11.3	9.8	7.3	21.3	11.2	12.6	18.4	8.9	14.1	17.5	7.4	10.2	13.9	2.0	5.1	4.0	10.3	10.4	19.6	4.0	1.7	7.1	1.6	10.0	16.3	0.0	5.8	3.4	6.9	7.2	11.6	9.8	8.0	6.4	6.9	20.3	10.5	1.3	10.6	15.3	8.5	5.4	11.8	12.3	6.8	11.5	9.9	2.4	23.5	12.9	5.6	15.1	10.6	14.1	3.3	34.9	14.0	8.9
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 7.0;Spermatocytes: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 3.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.2;HeLa: 18.9"									"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	4.5	1.3	4.8	4.0	12.0	3.6	7.2	12.5	6.4	7.4	4.3	5.4	4.1	4.1	11.7	5.3	7.5	5.4	5.4	4.0	7.5	3.2	7.3	1.5	3.0	4.4	8.2	2.4	16.6	7.3	1.0	7.3	2.4	7.4	7.0	4.4	3.6	3.8	3.9	1.5	6.9	5.8	6.4	9.2	5.1	7.1	14.9	9.1	1.5	9.3	2.7	4.4	5.5	6.2	3.8	1.2	1.1	1.5	1.7	1.0	0.8	1.2	2.8	17.2	0.0	1.5	3.6	0.0	4.2	3.3	3.7	5.4	1.4	2.1	0.0	3.7	3.5	11.2	2.5	0.0	9.7	5.8	0.0	5.6	0.0	18.9	2.2	3.1	0.1	0.0	5.5	3.0	7.7	9.1	5.3	6.3	0.1	0.0	9.2	3.7	0.0	0.0	0.8	16.5	0.0	0.0	0.0	2.5	4.9	2.7	3.1	9.7	16.1	9.9	8.6	5.7	10.9	5.7	0.0	2.7	5.0	2.1	3.6	7.6	0.3	0.1	0.0	0.5	0.1	10.3	0.0	0.6	1.1	0.7	1.5	0.1	0.9	1.0	0.0	1.2	3.8	0.7	0.4	0.2	1.7	0.1	0.1	0.0	0.8	4.8	12.0	12.5	6.4	7.5	3.2	8.2	2.4	7.4	9.1	0.0	0.3	0.0	2.5	1.3	3.6	0.4	0.0	0.0	2.3	7.0	0.0	0.7	1.7	2.1	1.3	2.1	0.4	0.0	1.4	1.9	3.0	2.0	0.0	0.2	0.4	0.0	2.9	0.6	0.6	0.5	2.3	0.7	0.0	1.8	0.7	3.9	1.4	0.0	1.1	1.1	4.6	6.5	1.7	6.6	3.8	1.9	0.7	1.3	1.2	2.6
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"		NA	NA			"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	15.1	17.7	20.3	16.8	31.1	5.7	20.6	23.9	26.4	16.2	15.0	27.9	16.7	13.3	22.7	16.5	13.4	15.2	12.9	14.6	20.2	13.8	14.9	12.7	13.6	18.8	34.8	19.3	23.6	17.1	25.3	24.8	14.7	25.6	18.4	18.0	13.8	17.5	16.3	15.0	17.2	15.9	18.9	30.5	19.0	16.7	11.9	35.1	22.0	20.2	8.3	19.2	17.3	16.8	13.3	8.1	12.4	9.4	4.8	9.4	2.2	2.9	5.8	13.8	12.5	15.3	13.0	6.6	6.1	6.1	3.0	4.0	2.1	4.2	15.1	5.5	4.8	4.2	8.1	8.9	6.6	4.3	9.5	5.5	0.6	7.6	6.1	5.1	7.2	5.5	5.8	9.0	3.6	10.6	10.9	1.9	11.7	8.8	10.6	7.8	6.4	12.1	5.6	11.9	2.3	2.3	12.8	4.0	10.7	6.3	7.9	15.0	12.9	9.9	5.3	5.9	12.6	9.2	5.4	3.0	10.2	5.7	3.4	2.7	17.2	6.4	8.8	9.0	5.1	9.6	9.4	5.1	8.4	6.6	8.0	4.8	10.3	6.3	5.3	3.6	13.3	9.4	6.5	12.4	4.8	9.4	8.1	3.2	2.2	20.3	31.1	23.9	26.4	20.2	13.8	34.8	19.3	25.6	35.1	32.8	16.0	27.0	17.0	3.7	46.9	14.4	12.7	21.4	22.7	14.0	33.4	18.5	11.6	16.1	39.6	17.9	14.2	0.0	9.5	11.4	15.4	13.7	11.5	11.3	9.2	31.8	29.7	25.2	15.6	39.9	17.3	10.9	8.5	14.4	12.0	27.7	9.7	16.5	21.2	8.6	46.3	32.3	7.2	26.0	19.1	4.0	12.2	15.2	13.4	9.7
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: AB_2675167, HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.3	7.6	15.7	18.7	16.0	27.7	20.0	15.2	16.3	20.9	28.8	10.3	13.0	27.1	15.8	22.0	14.7	12.2	15.6	13.2	17.5	16.6	11.9	43.1	20.6	26.9	23.0	14.3	24.6	19.8	15.2	14.4	12.7	11.4	7.8	16.0	12.9	17.9	18.7	12.0	22.5	13.4	10.5	24.1	9.5	9.3	11.1	15.1	16.7	10.6	11.9	27.9	21.0	32.4	13.9	11.6	17.9	15.5	18.3	13.9	17.7	12.6	18.7	16.7	18.2	15.9	20.0	12.7	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3	20.8	24.5	31.7	36.6	53.9	21.6	68.8	12.7	22.7	19.4	14.0	9.8	53.3	23.2	49.8	98.2	21.5	74.9	0.0	58.2	46.3	35.5	23.5	50.8	21.9	45.1	15.9	94.5	9.8	15.4	46.0	16.7	31.7	32.1	49.5	33.2	20.1	47.9	129.6	18.7	30.7	15.9	19.4	31.6	40.3	26.2	37.8	34.0	30.9	34.7	29.6